var title_f0_28_448="Nipple areola reconstruction";
var content_f0_28_448=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F54178&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F54178&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Reconstruction of the nipple-areolar complex",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 380px; height: 268px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nipple-areolar complex reconstruction is carried out with a combination of local tissue rearrangement and tattooing.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jorge de la Pedraja, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_28_448=[""].join("\n");
var outline_f0_28_448=null;
var title_f0_28_449="Liver abscess CT";
var content_f0_28_449=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F61510&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F61510&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Liver abscess",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 332px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A contrast-enhanced CT scan of the upper abdomen demonstrates a large gas-containing abscess in the right lobe of the liver. This location is easily amenable to percutaneous CT-guided drainage.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_28_449=[""].join("\n");
var outline_f0_28_449=null;
var title_f0_28_450="Sonogram endometrial polyp";
var content_f0_28_450=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F54170&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F54170&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 533px\">",
"   <div class=\"ttl\">",
"    Single endometrial polyp in 44-year-old woman who presented with excessive bleeding",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 513px; height: 223px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADfAgEDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5xAyQFHU8ACug8a+Dtc8F39tZ+IrP7LcXEInjAkVwVJI6qSAcg8UzwHqGlaR4w0nUdehuJ9OtJxPJFbqGdyvzKMMQMbgueemevSuu+I3xE0zxv4RtLe40y4stcs7+a4idJDLC0MxLyAszbg3mcgYIAGBigDzLNGaT0oPSgBQeaerEdCaYOtLmgB24nvmtLS7BrmN5h95D8qnvWfAisGZyeOgFdBo5aWMJaqfOTnr2oA9G+B80afEnQndTDKbjZwcA5Rh/WvX9Egn07SPiQ2oW5a2e4DxKy4Eg3uMj17V876ZOlrdTC9DqXGeOCrdjkdK7HVfiNr+ttbWM1881uoAHmAAMcYycDnigD0n4bX17F4I8ZgySrLDHHJDEzH92CG6e3Hatb4GSSXcXiZr1ZpxJ5DsmNrsfnzjkccCvH4vFepaZLLbbiqTJ5MrAf65ewP0NaFh4ivPDtws0F5LDJcDb+4kwSo7GgD2DW4bmw8faG1mr29o10haFySzKx2k59Mnp2rpPE81sdG1c6NHFNP5wjvo9xBGDzxnj6/X8PD/EHiTU9TubOd755GiAxPyroOvGK3dG1G7eKa5sgkk98v8ApLFyxlPrQB65pMX2nSNCeC2DGAhWKSACEAjIIPXgfpW5qItbSzvLictDG6fvpUzkDBGfwzXm3hnVNQBa0VZLeBzlXjJKo467mr0vT7lbiwEzyIy8hmOAODjmgDntJsrTxLpsN1NMl5Y8G3ZQV5UkNuU+4qO78A6XIH8tWXcGJ6ZyfT0rQ1jxNo+lpF5moRxIG5EK78+3HArzXWfHyv8A2mLOS8dHkUQEvsXP9719OKANu/8AAllLMQJvIl+VYySMJjqT6mtqe10rRtE+xTva+UB+8MZBYn+82a8fufE2v31qsciObdRvaSFQW6/ePtWaNPv7jTtSkhF3dCf5uVIUfUmgDstc1rwtonhxodOgkuEmYeYY+WYZ5yT0zXGeK/GGkX+nxW9tDJHbQSI32cDIbHbPX8aoaa1te2EttqNzLb3USMyqoBEuOg9K43VpIxcrHAhSMIUJ7se7GgDoPE1rpfjOKOKwWK3nghM0lwQBj0Qeorx6+tZbG5eC4XEint0PuDXdX08djGPsCMrNEPmY8sPf61z2oXEd3GRcooduVbqV9qAObJ5pSeKWVDG5U/gfWm0AKTTc0ppvNADs0meKO1J2oAXNGaTvR2oAXNdH8Nz/AMXG8J/9hiy/9KErm66P4bf8lG8Kd/8AicWX/pRHQB77+2p/x6+Dv+u11/6BHXiPhb4c+I/E+kx6ho9vayQTTvbQrJdxRPNKq7iiKzAsdvPHofSvbv21f+PXwd/12uv/AECOuG+FnxS0bwp4OstMvv7VW5ttSkvXW2tYJY7iNownlFncFM85IGcdKAPG3VkdkcFWU7SD2NIDU+pTw3OoXU9tbrbQSyu8cCnIjUkkKD3wMCn3OnXlpY2V5c27x2t6Ga3kPSQKcNj6GgCuoLcCtTTHeMFF/j7jrVC1Azl/u+3Wr8Msduo2neuenpQB9Ufsq3jy6ZrdtJKHMTxEDuOGr3ivgzwb4xv/AA61w+kajc2TT43CM8Njpn6V0sPxc8VO3PiG8GTgfKuP5UAer/tL3MkVxoscUvl70kzzjPI715HYRTebbJaM0koPzxliQ47Cl13xNqHiq7sP7evZbj7P0UgYK55PHc1c0zXU0ie6S0gjCuQynAJT6UAdPoWtt9sDaiPIEOY+Fxu9sV3uoz2t3awN9jdFkAAdTgkHtxXksOu2tyd7Ef2gT+8VkzvPY10VzdTu1pBLeXCrKo+WH7qMOn0oA6HTlgGoizggVbSJtryv0Le9dEhjW4ZIpCky/IDHzj3+lcRY3KxXk8E7uolTo5+RT7+5q9K0kqtb6Y0drO6gPcxtgke3vQB0b6odLnc3kksrMB90fIfTd6VVsru01ISCGaS3SUn91GxXnvg9qytXtLfS9Gkea7ubq7ZcB3fcSafpts0VhbvGEKMwOQx+X1JoAv3sz2tk0SCSCOVvKTe+c/WsiaGW3vIUVDGm8RKwHL8c8elW9cgt4pLa7uLyR7eHc20Etz64qlNqC+ULy6vJmvCMQ71KhVPpQBU1XUbrRb5ZEcPDGSSskpAkz7Ulj41ijvPtV1d3IvcZ+yITtX29MYrktf1ad5JXls98Wcb3G7d7+1c5qE9zNcpPGVjRhkbDg4x0oA+q/DetDXLa2xceXE45Vz83HpXR397FAnlLMEIXkqeQK+T/AAl4jlsZG+2vIG3bQxP3Vxxiu9/4SWFmh8zVbgzFkIVclSme9AHu1tchbUPcOc9VLjBIrL1e/g8tvtTyBT91ErzaTxij+IwEup5bdohHGHJEYfPXmt/UvE+hwaW8N7Ij6rtIRR8xDe1AHE+LvCJ1+586zjETnjZ1BHvXkHxL+HE2i2326ydJSuPPgT/ln6sPavoiy1KdfJt2RYHKbnLHliemK5jWTIN2GtnWabaQBlnz2NAHyY2RTM816x8UfAE9tNPq2mW6JCxDS28f8GepUenevKHjkVFkZHCNkBiODjrg0AJu5oBxTM0CgB/4iim5ooATtQepoNJQAvWk9KO1B6UAHereo2F3pl5Jaahbvb3UeN8T9VyMjP4EVU7mpGdpW3SyM7YxuY5P50AIrMoIU4B6ir+nXMtsw27lU98VTETZBGGX2NXnZE2hZTsYfd/u0AbVvMbhJDh2kJAIzkNSW7SWrEuzqSw2ll6UujMlszoc4KcMvJNVrmV1lVhIZAT8p7jFAHQ2tyt0f9NBSRfmRhyPxFTQRPdSebKC0YYjYvb/AAqhp6SbNk6eWztkM4xj8a7LR9OWG8hnjiimSYbJMSfmf/rUAbnhOytmCTXd5GGUb44ZCcuuMAEf0rQg8QT6dqUX2G3Hzo6m1OECAfxZrC1rTEtTMsc0Mc2chmfGYz0wR6VXihtrJU3ajGZXH3f9YOfQ9s0AdVN4j1Cz0e6jUzR2k4LRBWyo/Gm+D2vpbZnN60UBkDsLmQ7ZD6AdaoeEle8eeO/RjZQN8kTjr71saVd6JFfP9oguMs+6OZ+FCdgq0ARazMwkVpY5rKMZ8qOHDbifrVLT7O2lj8yO5cPICFgY5Knv+dLquqm41WCdTb+R5hitopX+9nv7GtGyt5IJ1WeWCG1i5WdcHc57UARRvdaLYaigkMUESDYCAS2ep/pWHrPirVriG1s7aGSC2wHYZ5cd8n+lbWs/ZIod8lwfNlcfeO4kHpx2Fc3eaReFMw3SyFxtba3fsBQBVmtd8MlxfzIsjHy41zgheprLuraSDy4hGm+ZCwCrltnYVevdM1KFoFviI9hDbmPUelaNnqTRXjrGgZV4WdULEDvQBh69oHlmy+0skbyx4EanLLjsfrXnmrxNYXk0D53A/Ln+GvSfE8k8v+l2JkRU5jEnJc9zXnWrNPczEzRlpATuYDv70AZRMcnzOSSCDg9W9RUuszWt1qdzc6fZLYWcr7orVXLiEf3Qx5P1qtIpDEHOfSrlp5ZtpFk6+hoAzj702nsMEim0AL25ptO7UlADf50tIaKADNdJ8Nv+SjeE/wDsMWX/AKUR1zddJ8Nv+Sj+E/8AsMWX/pRHQB75+2r/AMevg7/rtdf+gR18vg8V9Qftrf8AHr4O/wCut1/6BHXy8OlAC1NJdTy28MEs0jwwZEUbMSseTk7R2zUNAoAerFehxU0KtIxAJPc4qDtUkErRSBkPI7UAdDDbxvApAwcct6VbFi0NpuwrA8g1V02Vp3IcbAw5rTmv3iha1cjZjh8etAFvRbS5kIaMgwnhmB4HtWulkyTyQwxs8hAK55ArB0O9miuWEMqLESMoTw1dVbXd0zedEi7kGMEZxQAy1nhN5bPdWfkXGdrEHHPqa7SwgNvMTFIfKI3KSQSpxXJ6BLLqFxePqVkZVC4D4IANWNLXybJ1kd4ZBIQCWySP8KAOh/4SQojw3unKxuMhCw5f8afDJZzxtFHvtYpiMtgkAjtmoNNsZfsCDVbm3IRSkPPzqD3966OwlsH0ltIa+t2uoEwJGAGB1H40AV7R7CNfsdxHcXF2f9W7k4X/AGh7CtLTNVmtPtKrdw3MaEAKYxj3zxWXbaYdQaJoJwrKxUvn5iPQe1aT+HFtbcNe3scQVsrjAD+5oA27Syt9RjlF3EXjc8qBsCVzHiRPJ1GGFE+3W6DC28a5IPuat6ndrAPL06aZ7o/MxD/ux9afpOs2cdtJMYgsi8SS5yAaAOK1ncTPHHbG1wm7ypTkH2HvXFXEczt50yqvk/8ALJMcj0xXqOqrHds1zYQmW7m5LzfcC+oFeWapJIbqeOW4j2qSGkTA/KgCCa6t7liEjKnODH0xT/7QeK6RBgpH1YnDY7VjRhi0jxln2cjcevvVKSdpbkYQheMjNAHoWl3lvf2nmX11IZI3wqAEZH4dfrXVeH4bexefU44JJCOQZSXJJ9K8zsZZfLR4gsQBHze39a6jUvEV5F5MCGFEAyEUhvxoA7nXdQvxcW0rIy+ehDAYygx1J7Vk3F5bJDbm1LyypyZS2MN7dqwf+EskksnTULglmGBtA3H/AAFVf7RZbC3h8tDDvBJBy59qAOzjuNRvra4uLoRsiL8pbhF+vrXkHji01GXS4Yo5IzpVlI8kVuiqoVnOWZe5yfWuyn1m41PULfTDvis+pRR6DPJp/iHTLOS3MsqsDGMICcA/hQB4R+tA+lbviLT1jnaa2j8tCOU/qKwaAFzRSfn+VFADqQ0ppOtABRil6Uc0AIRyacilunNNyc8U9HKqwH8XWgCUl4mxjbninthZVGA5XqexqFAzHCgtjtVqDd9pKkBM9QaALKl5LgG0LKEXP0rV0m2guNxuQQzDIKjgH0NN0mxmcNMoBjQ5bDDJrSs3DJMkco8kHG0j5/woA19LGo3l61laoJWCZRGIxwOvNbOmRXOpTTW9rbf6Wi/vYNwUZHQj3qppGlPqAguLG4EDscbt20x/15rSguLHS55t0JnvQT+9hlIBPofegCHxBaywaXtuibiVcNgqf3We2RWXDplzYWltc3QCQStuO052nscVo3pvzYLKLzME2W2K2Sp9GFQ6Wst1erHdyqY44yAH5X/9fvQB1svic6lZLbQWirCnBkiAWSQ9ttaltYw3umqt5EIRanO1ZMSk44GewrjxDFb3a28sflSA74pI8kj8Ku+bcWf+ttyrSEF5ich1zxn0oAt2top0dJxaQtHlsK/JVge31qjp0Mup3tzGtnLIvlZWOI4VXHf61Y8SX1xCqrAsERVctt5B7cZpPA7RXF21rcJcMkih0lhJDN65PagC9penwwxTGeSeV1yxXI4I7EnninaVbiERyly9iZGkLFSG3Z6CobrVIopZjDm3uLbckYVOWOeh9frWvpV1pi27XlzLLOcAmMHKBj60AVbm+N9eiXSNOFxLGp4mYOF9/TNV21eG0tbb7RZlYfOJuWUfNIcf407xLrAkJOkQQW7ImJGRhuIPYVRsbK4t9PBuv9Ki/wBaVQFiT1AJoAz7++h1q4dprdUTd8rnICqO1Zet3dolwxgtLc2oXYrYwM9yfU11JiudS0h5XhVJF+UEpsjiX69zWFr9hY28EVpayvK4wZAi7lPqaAOM1XT7Bos2imS4cZ2gY5rjpo2jcq2VcHBFehXMq299utIVVVGAHOCPc1kanp9isnmzzq07ElwnQUAcWabVq9VPtD+UP3Oflqt0+lAB2pO1OPSmmgBDSdqU0n0oAK6P4bf8lI8J/wDYYsv/AEoSubrpPhr/AMlH8J/9hiy/9KEoA99/bW/49fB2P+e11/6DHXy8v3a+of21ubXwcP8Aprdf+gR18vdqAFoUccdqKVaAF6A+lWbOFJG+dsVCELHAHNTpbhkPzAMOaAL4kljT9382OM+tTxNv2CfcNx59MVDpMO6WPDj0IPc1sRgF/JuMKobkgfpQBu6bp1rcW0fmWrKgOfNjPX8K2kNvNarJpwncw8MmOfqa5+2W3nxFBK6wk4BzjnvT7iyuNNuNtmXdcbmwSCKAOs8LzacdRlimvp4opYwG4yobPSrPieG2sdWtbfykWIpzdK2dw9xXPSXE32WLyolAOFKkYz71taPZS2t+v9oQpPLt+TbyFH40ASXDeWix2OZImG5XY4wPb60zTI2GpSyyxKQgEmc/eHcn1roL+wso4o1glIlbkM6/czVKWzuYZRPczRPa26bg2MK57CgC/eareI8LWaILY4LOvJA7jHY1q3T2tzcW6P58kRQufOb5QfQ1h2V8Lh0WXTDLNMhO6NgAg7ZFbOi36Wdk1nJa+YQ5JRR9/wBqAOZ8VeI5dUb+ztPjtoY4zl5YiTx70vhp45ohb3lyptMFiFGHJ9/atG/trW61QXMemiBYkO9Bx9B71gX1rBJenUpZTaSAbslfToB2oA6DWbdrPSWmVJDBKcREHaxXtXnesaBfRWzXU0Cw2gGQSecHpXWtc+ddRXmr3phuGjyi4+THY4+lY2oQyXEMkq6msxnbcqOOnpgUAcXL+6tjIHWQrgYxiqdnClyfPlkELbgm0DIxWrGWtknivGBBOAVHH4Vl6gi26hI5FIYcigDZnkhW2bDEiNcAKPvVmWrO+HXKvzwayYXkjHGVHoT1qS0u5Jdw3FmbgewoAvW9zKxlL/Oo6jPat7w5fRIuY1XzjkLvbhfeuSlneJfJfnPJAqex1dYHysQ3BcAHtQB2s97cadceat1FJM4xtAqlPq80zNJPuLnhF7ZrAiuVJ80HM55yegp9o8c8oMzEyk4ABoANRMlxcnzmAGMnHp6Vz2r2CxP5kHKt1HpXV6lbeWh+YsRy2BxWJdylYgNvJ6CgDmMn1NFa32cf9M/yooAzWxxgUlXtJXT2uJRqz3KQ+Q/lGBQSZsfIGz/DnqetUee/WgApD07Uuc0lABj5v/rU4cjimd6VScUAXrAv8wjKg9cHvUqD7QCcASZ+Y+1UYdzOAmQT6VKm4uVDH3IoA3tOgmMoiTaRtyBuxuq7pltcWupeasvkyDnJ6VjWEqxyI0RJ28Nn0rf0K4e6M8QlQeiOM/rQBsz6pMtnF5LrviYoSmMsDVCFruC6jkRXJ3FmLDpWZEvn3xEcYjVCQwJ4z9a14rmRyqwl0kjOM9VxQBpeI9S8oLPHyZYwCgXCqT1zWRorI7TFrhowOVO0mnalJG4aK4dSvVWHAJ9K0/DP9mpDczXpmViu2OJB8pHrmgC9oURNy73uq+RcKflZ84YelWpI7mWYPDKCiPkkZ2dfWqdnpP2ixDhZJriSTan90L7ntXQGwvLOS2s7i3lgsmX5lA3bj7n0oAtRQWUlr5s8scly/wB2Ic5P19KfY6vaWUwtrOKawfZzKzBmf6e1UpdIggeKCVhJKVLD+HatJ9tsAzRRoF2YjXMJJYdxmgChbutxc3zM0siOSyyMDhgOpqQfZjpsdxHCzyu4XarYXP06Cr/2gWOpTW6RTpHJFtADAhQfQUi2UOnaXEk0bOrN9zOMntj/AOvQA640OKG2tLyCKNSJAzCV+DzzkelbHhm6vry4nuJ54Us84VVbauPp1rn7aVotQW7upUWGMbXjQeYkQ7A+prRjuZFmuJ9JgS68xsgMenHXHQUATa5r7SWdxFPO0yh/ltymxAnYk9TXDnV7zyLqGDyIvPOd64G1fSr2o3xvxO97HItxIdpbGFBHtXNajojwWUkzXIVd2QWPzE+woAzo7UGOWSWdSoOCc9T7VJPEt9GCYlht4h/F1Y4rNL+TbggA57s2cfhUdtJJLH5u9uXxigCisUaTMJj8gP3aoTnLk8AHoBXQa3YTeXYyJbvFFdRGeGV8DzY9xXeO+3cpGT1xxxzXOyoY2Kk5HQH1oAbniremW1rdPcreXq2nl27yRZjL+dIPuxjHQnnk8VTPvmkoAT9Pak7UtFACdq6P4a/8lH8J/wDYYsv/AEojrna6L4bf8lH8J/8AYYsv/ShKAPff21v+PTwd/wBdbr/0COvl4dK+of21v+PXwd/12uv/AECOvl5elAC0Cgd6kgTe+D0oAkjG4Yxk1r2NqEjHmgHcM5NUZVEaq8bgspxV/wAwzKnljDYGcdDQBpQxRrELeOMF2+6x4xVxgpt0WMhZFPVuh+tL9luU06FpQI4weCoyTVjSLc3mILt1Un/V+YvLUARQWNzdymRHURZ6K2Pmx1xW9o+i3txI9pdsVd0yjFyOKhtbYQ6gtvNGYWU7THjhj2atuxVoNXiN1l41GNwy2PyoAqXk1xCkVlbDBjb+IcFvTNdF4a1G5giliSCI3a8yNJ0A9B71oyJa28/msiT2TD+790+uKnu57KXRvPsrZDcZA4HzOvvQBm39xYX9mDPPNC7H5ir8KfQ1oaXrOnPaDT7kxPGBkOw+VhTHtPD8tsomjf7QVw8SIcqT1oi0k/Yo/JtoWsoTtkz8sjL+NAC6X5t1fXK2CxPECF/dnHHtVi9huJJBFBJsUMd57r75FdDcpax+GpDZww258s7DEQrKcVz5ubi6t7dbQhJosAtuwsn19aAG2mjJBEZpbqW4uh/C+cP74rmfFMVt5fl3Usi3Jb5N3Ea+xFdxM+pzSwrvtl555yQareIYtMuomhvYIhfp9/zFyCMetAHKRaGpsPtMkrRuE+VpMMuP9mubsTbxzXKMI1VQfLl5JNb7TXUzNb2vmSRx/KRN9wDsBWD4iRrGMpNOhL4PyoRg+lAFLUJUubDa1oPK3cz4HzVyutQ2ojElu4J4+UnpWtqxnjtoXjeR4MbgOQPfissy2pgL3KMrkHgDqaAMaVHOZQGwv948VOrrFGGzg+3UUvn2pjKlWGT8qnpVS8wAnICE9FoAS5mHysDuakaYtGTwapN/WgMQMAmgDRsbgB2388dCeK0LKeZ3PkIMk4BXj8qwthRAzdD29a1tK1DysKsZ8vPIzQB1VtbpJaN9qmI5zhTkfj71kanDAjbYRk88nmmvqauNuwrF2UHqahW3nvJTtIUckjPQUAZnz/3loq19ig/56LRQBhMcmkoOP1pO9AB0oH1ooxQAHqKUU09aVfagCWKRo23KcGpoTK026MfMR6VWq5Zz+WCuSp7EUAOt/NidmA6HkdvetDTZnju/NtSF3DJDdDVEuWjZTzk8MB1q1a5dmzlMrt3CgDpLG9gaIxMQnO5sDJP40+e4tZ7tPLcxxEFTHg8n1qhZIbqMeV5aNGNp9WqezLSvhhEB5gyx4IA7UAT3tuohh+0bTHE/JU9R6V2miXGk/Z7Wa9sA9qMs0gO78CK429a1g88LIWVhgE9qn8NsUH2R0aWJ+QF5/OgDo2u7Q3lwNNa4RXPyBM7VJ7VqaJr5srWWS6dp7xRtYTZbB7ECsGe7g08yG1EsZUYBVQCzYo0y0F0YXmuBDEch2LZZj6baANCC6kvGa+MrNGMqC/cjkgj0pbTzoTI6skEzjejONxHpg+lbmiyWGmabdRXLrPliciLaEHv/APWqjeapa6hMks0W2BMbI4xywHfNAElhrdvJG1wzmG/Xh5AmQwH1pJrtLzy4oYUeKZwXMhwFY5PJ7ZxVufSf7RjMtnbywIo3SHbuIx2FY91pdnaRLO8szyPzsAwxNAHVaBovmadI1w0EEBbaIox5m4+tFt4cudOkv3hlAZB5jBzgOMdAB0rF0bVIt/lW1xPapAARtbcGx65pNV1DWL+6ae2nkaKRdgO7APqcUAZJku9Wt3eOER853BcKgH1rC1CylW3neaRfK+6rSdT9BXS6ZJL9hkh2OJgf3jMTgD2rC1RBb2UqKwlDklyOdo7DNAHFXiwF0WJiwzg+9bfh7SLG6Nzd6s7QaDp6ia9ZCd8pJIjt4/8AppKRtB/hUMx+7WZa6Xea1qdnp2lRKZ7h9sYY4AOMlmPZVUFmPYAmjxhqtu8Vromh3Ekvh/T3Z45mXYb64bAku3X/AGgAqKfuxgDqWoAoeJtevNZ1m6v7polecgCGBdsUMajakKDsiKAo+mepNY0zbmGWyaQn1ph6f0oAmzGUbPB7e9IUXbknGajycdaC5IwTx7UAOMZ3cEE9eKaVKjHenIxxhTgd+KGI5xkn1PTFAEfvXRfDb/ko/hP/ALDFl/6UR1zhrovht/yUfwn/ANhiy/8ASiOgD339tb/j08Hf9drr/wBAjr5fA4zX1B+2r/x6+Dv+u11/6BHXzCqEkAdDQA3GakiyCAB704wuDjBPrUrxsw3AHjpxigCeOCN5Mb+PftWhYJNaK0g2shPGcVl290UyJFDL6VZjvI8OMYX+dAHV2N+t0EFzPsZR91RRqN20QISdZcHKsBgr9K5CK+aORpFAyOlaFs82oMRMTtbjgUAdLb6veX13Cruk0iAbSwwSPc111o10I2msoViuuAyk5zn61yGn6RIJEFiJJZCQAQP0r0/TLj+ztOEM08cd4MMsQALH2NAFjS9OhktG8+eV5y48yEggke3auig/srT2nmdVXaAFjkX5SPTPrVnwxeBbwm8aIxTqAiHGUbvXU22g6TdFopx5m87w2fumgDjLi/0a5i826042spXdHIA2fauat9SljkaO5lNwzt8zFCMg9DnjoMV6R4h0kTWy2lxgQxnCyx/eGOmaw72J7/Q7i1S1jDJ8vnkbd4BHNAGDPaTXqRx2lpI7Dq6ycEH2zTb+y1TTIUkMG+144PRfb1q2jLYahbpGksUbgF2RiVQjua0dTukngl3XDXYPQHhQKAKMV8kzLELSQuRgbUz+VY/iCwWzmLw28ayRrkyTTElh6YzVjRby1hv3iu7mRHfncjfKo9z2o8Q6lY29q82nxreRsdrOwLFh7UAY13q+my28U9qp+2DG6JQce/FZerXMNxaGa9i8x1GY4fTPc4rT0+DSnlS5nlEAkXdxkt64FUNa3qLm6sbf9yPlUyL8zf4UAcDqd3N/DIAo+6uMY+lZNxC1xHumfewHQGun1OJ7q0kubi3xbW7LHJNAnyRu3KqzdASOgrlHUxkyRE+Ue7UAZcqktskAXHQDrUQRidrlsZ61pyqN3nMVJVeg71TmkJRXY5Oe3FAFCQFWIwfxpFyDmp7n5lUjJqvQBKzNJ0yackzxrtU4zxUQJHSgH5vegCz5jbAZHYEdBj9a1bW9xb9CsfQnvWG0hbr0q1bkNERkKo65PWgDY+3WH/PBf1orBxF6j86KAKxoPXj8aCeD7Gkz/jQAuaO1J1J96O386AF70qj0pBk4pydRzjvmgBSCpwQQferCQSeWJdh2dj60k0jTbTt+ZerCtJb8GzePapz1FAEUKlox5ZA56nvVyCT7NOvnFZRVS2jjaFX35JPzJ0wPrWhaGylutsY25GBvPANACm53zu8AeOIDjHY1cWPfYSRi6JywOdvGfrSWulx3975cFykUwOCr/dNdFdeF9Qs45Fu1CQsBtdcFT+NAHLR28soaMSq4TIILdT7Vu6BqMukBGvoSAw2qTxxXPvFJblopEIcNwfWrjW8stlm4dn/uKGyaANzU9X869zGR5Y52Hp9ab5ksjxyaZl5Pvqi/w+tYdpZzBslJGVztX610uk6QI5YftE8sLEhUIXv35oA04tRku1tobhwy4JfCZ8tvfHWtLQrOe4u7uKG2he13BS8h2j6+1XdO0i3s9RtLTyy8tyG/fM3Jz0BHpXqNn4Rtxo5t7qKJppMAnfgEUAZujWMKWIs9S1NJEXj7NYj72fetLUZNH0jTkjtfD8XmbSRNdMOPr3rG+y2em6slnDcsvk5yN+0hP72enFZ3ibUo3h/0BzLIeA0vzbj+NAFPT7RdRP8AaKWMccoc7lCBUI9ap3Fq/wDaPmWpjXY/3w25B14x3NbOnX0L27xXdn5fy5k3yYGe/FJb6lpcNoqaZBGiI5B+UnBoAxdY03VJ9Kkmmg8oMfvRnG4dq4yaO9kkXTEt5JJGkCrHGu+RmPQADqT6V7fJZy32jGeGJXRY+JJvlVR6815bFra+GPFI1yWL7clkHMCRELG0xXahJ67Rkkkc5AoA5/UbBvD+kz6fh7bW9UixqBdtrWVo2GW1x1EknDyei7Uxy1ea6rHHE/lQsZAv8XvXe+J9XufFGpXOr6nK0lzJjcY0C7iBgAAdAAMVyd3ZPFA03llVzwW70Ac8w6k9hUZHerssI8hZCTvY/dpghjVWaQ9uBmgCr1pGGKeeOMVGaADPPHWlzxkcU3vSjpQAV0fw2/5KP4T/AOwxZf8ApQlc3XSfDb/ko/hP/sMWX/pQlAHvv7av/Hr4O/67XX/oEdfMtvC8xG3Pavpv9tMZtvBwJwPOuv8A0COvnSxV7dFlXJTOeaANzTtCaWxeUvuZVJCk4PArFuyoPlE4de5rpdM1KW5t5LcojblyQxwfwNYc+nk3DF1YAnkHqKAMeSPJymcH1qIDG4ZORV+e1eNiEIwe9Rw2xlBUHkDkA0AVUGeucCu68OX0UdmE+zh/du1cYtu5k2gfnXY+FobMSRpdBxIDwBzQB2OmWKrLFObtoyW3nHBU+1dC2lyz38c8MrXMUq7ZWI5Qjp0qfR9HtZLCNJZmxJyk+eQe2RXRaPpU1lJL58TqBgCSM/K/vigCHTNEdPLZ7lVVGPMT5OPeujS7uoNPm2gleiSA4JFYGr3t1pmrxzWdrDKjDDAvjf8A/Xra02dNZmSKeNEwu7ygcMD0PNACWHidTerHcszQImCXXkn3rdhis9QWOe3nAjQ5KKOPxFZ15a2VlcCQKqSoMYYg7qSKS8t7mW9gMcsEgAaJFxt460AQ68ttJN5UV0IWYcKoA3e1czfTywA2VkhaYna7MM7QfStHUrmK/eS6urXypY12Kwbt64rlIJEN+8ZnkLMQ6yFeBQBNPYJpcsn2vcFkXk4HQe1Yd5qt2RDYWyxXFkgOx0QqSPerkc8sUtyZ4Zrsc+XK4P48elYsXiq8jiRbe2hjEfdhuNAF+/8AEy2ukxWllbgXKEAGRMBR3+vNafhOS91iZF1FYraLy2mlnZcRwxgcyN/h3OBWFpN/Jr/iSC1e0e8vbk7YLeJcFmx3PZQMkk8AAmn6xqsMxm8K+Hpo105bjfeXwk3C/lTkYP8AzyQ5CDOCRu6mgDC+IOrWusS2+naLJPHoVizvCj4DTSNy08gA5c9B/dUAADnPGfvjbgMqiJOxHJrvNXs7bSLLMW2VmXczddv0xXH3d0PJaUJ5gPIJ4x9KAOfeYJcEhQ0eOVJqDCysXyETuKtPbtdL5n3F6Yot4rdCfMcnH3aAKdwJTCC2Ag6ZHNUz1rR1D5vmDMR0GeKzyKAAdKQ9aO1KMYOaAADJp2McZ5pn40uOOtAEmI/VqKizRQA09KKO9FAABS9qAOaDmgBBkninr2pnerYnQ23ltF8w6MKAHQXO2N1KKQeM1CkjICAeDTWHyggjB9KVVLEADJ9KALdko2PvOARwM4p9unmfKp2n1JxzUNtFl2V8qQOmK17WO2uLYqrGO4HQHoaAIyrW/lsjMrk88/1q7puraiQEeaWREyFQnIH4VQlLFVVyA+cYzyKkuJZIoVEQIA+9jv8AjQB3Wk6zAmoW51axtrpWxlJSQVA9O1dJYeJ9Eh1ScPoduSOUZOVUdhivKEge7VWurjZtHANbGmS2lq4S4fzW7MCRigD0Sz1O3vLuZ5NOS3XeWGxRgn1we9bk11ANPiJs3eZmG7zFG1V6Z9q8we4Y3EjKjCMfdZXPH1qzHeMlsjXc87oDnywT81AHZa/pskf2RbRWVCc5jfcd3Xk9hXWadf3BsreG5MfmOB5bI5Zj+FedaXqD3OpQJMbhuDlFGOOwFdP5VzpFympm1YRyHaHaTeyj1AWgDs5LNLq7ZL6EymVQqYXYAP8AarOufDtjNL9n84GZSDkdEA6D60+0u7u/s7ieN7eGL78dwWPzEeua5w38zW8im5jj6mZ2B3E+tADJLVUe7jkuV3xyAxhvvtjsPauv0n7NBaIWsYp3mG52Xov41zdjp5YwXXz+e48va4BGD3xTtWuZrGSSyNwytKvysemO4HpQB1HiK8s9U0ZhbzSzRR8eRCeGI7H2rjrzw5Z3iLPdyxhY0/49YuefQ0yKW40y3iihud8Eik4ZMfUnFbei6fG8YvETZGxO1CMGRvWgDzXV7UWtxMtpuRjyIduMCuS1yzu1W3a5YtHnJwPlA+teta/4YuFnm1C7maKd+Vi+8Me+OgrhNeS4vbdIjtbC5OxuFoA5mbTReIxih8uNBnJ4A/8Ar1yc8ZSZh2B7mu6uZBDpnkQyL53dVGcj3NcteQuCzfLuA+bIxigDIOT1phqZVy5HbPao3GGIHFAEdHaijFABzXR/Db/kpHhP/sMWX/pQlc5XR/Db/ko/hP8A7DFl/wClCUAe/ftqcWvg7H/Pa6/9Ajr5stHfymiUnDcEV9M/tlx+Zb+Dvaa67f7CV8120DNJhCMA8GgDWs4mPl4l2bT/ABVszcuUkUNIRuDZxmrHh/Sre6i8y4kaNyMBTypFazaFLNDLbkCTYf3ci9QPegDze9WQysqk5zjFVmSWEbjlSO9djqOh7IC0qbJF53dRXKX6SR5VskZ7nrQBHDJtcFixOc16H4ViT/QbuRgQswBVui89a8+glRSCV5x6Vp6PfNA5fcxQt91T/SgD3HxfYi5tYltp8ybchIuhPY1Vs7vVYrWGGS6eOVQMbTkfiK0PC2t2moaRDHeyxrIjYUlBleOxps0hEl1dQ8iA4DLjP1xQB0tj5WpWa3N2oWSMgYHRifSt4adbafMqlwrSrkMByeK4eDVo7azWeWQOkg3I5XhTXQ2eoMtmk1zdSz+amAY03E5HQelAE9xZLJcyGV3gSQHcxIO4f0qA3UK2i29uGeNDsMpbAUdunWs68h/tE2ttZi4R4yOJTwR3B5rdTRLmygVLWWCRX/1iN1X9KAKsH2aGymd7YreYISQ8hz2rmb3Q5rbMk0+2SdsqGGQD6V1epaaLW3RlLmUENjfuU+1VJLhTehpI2aNRt8lzkA/3hQByusteaVBCshd4GP7xn6D2ArE1WzjeCQWay+Wfn2wp1H1r0DWdGg8QRLFay5KffErYxn/9VZy2p0iyktVn+Yg8oMqPYUAZ9v4s0TwV4Cn8PRWn9u3+pxtLftu8u3jMigCNn+8xVQAQvfPIrzRY7K3tlkEBkm2YGDwa0vE8QA2ksOTkBcbj/WsTSAluwM90insuN1AFuJ7nUQun2/lQg/ewuSO/NZ91pNtZmSNrkTSKuSVX5R+NdPBaw3iqbFGefBMkyHC49DXO63p7REQvM5IGTgcDPagDj72ULIyKOCOv+FU5cEBlG3HbrVjUkCT7c8dKrIiNuzJgDuetAEaOuSXqSWANH5pcBOynrVVhg8c0FvlxQAntSClFJQAnel7UhpR0JoAM+9FGaKAGkD9aD14pexzS454oABSdqcAM8Ggrzg0ANxz1qxaxCVmBYAfWmPEyKG4KnoRTUJySO9AAw2tjI444q3ZSJHwybjnvVQ9STV2RLcWwaNj5mOQaALNoyzXTqjKjdt3erLOjwmNYwJlP3hwKzYbaVD5hjJXqD2q1YXKxyOZkQgnnI6UAV1DyzgEgOO5q40M5+Z3y2eB1DUjRgSlsKpP8Prmnm3kSRDJlk7AHkUAWLSOZI2mliwucfQ1p20iPGkpTDrzu25z9PektISse8wkxLyxY81pq8t/p5WFIYtmRhV5IoAa91HGRsjmLFssWOBVzTmxcsbqQEnoroW49qy4YpBamVJgFjfaVbrmuiilhvo7WSESx3EZALjGAPegDQS4srZDIguJZmUqA3yYB7+tdBo09y2jsD9mjjC/fk3Bsf0rCkS5a+iNzMjoxCllAJxn6cV13iGwQaQEiuCSy88A544FAHLaV4m+y7bbYs0SSHO9iN6n0roYtZW8uw0em74z8jIyZwCOvvWTp+i2git7hMp5IJaQrlnb6eldLp9x9juVmZf3bJtEjrtz+HYUAR3V5LaR+UhdIlPKyDafXIrAZJdY1CFjBIVR/uO2Mj1FdLe+IBNesLyG3khixs2j5c+/ua53xhq4v5Ld47Z7KXOwSqcDb9KANXX7uxkEVurEzIu2Rl4RB6e5oSeQXls0MMkNmibFlLEt7nFYs+qpZWlvJaqkkn3ZHlUE/kKpzaxeXtsbcRqGkO55snOPp2FAHoGrapbSaG8elrPO5H7xmHLfj2rx3Vp1jtZRb2xUk/O5J4JFdodXlXR54LeSWUKm12OEX8K801ea5kkVWYtD22j9KAL2h6ZE1rLM0sbMAclznb+FYOrx4woiDAnJbua29Mu9NjQSyB1VB/q06sfc9q2v7Pe8sVmhgWIscpkjn3oA8/m0weaixYUkZxXP3KBZWUAcH1zXVyuqz3JumLyBsZFc/dQsUll2BUzxQBnfjQaXvSdc0AJXRfDX/AJKP4T/7DFl/6UJXOV0fw2/5KP4S/wCwxZf+lCUAfRv7X4do/ByxgEma64/7ZpXgWmR2rROs/wAkg9uK+gP2u96p4OeLPmLPckEDOPkWvAC0tyD/AKP+/PUKuM+lAF7Tb9bOdtkZeJuMAmvSfDjM0BPnbd5+QN6V5rayC2jCvCyXCnOGXhq9Y8Kad/aNvG8SrEAB+6Y559Qe1AGZq2h3N/A6uqRAdGDcN+FeSa7p06XU8Zj5icgkHivoTxFo9/aQxNA2YlcbgCOlYfiS3SPSjLBYJOzsN4xnjufrQB89OhQkYNWLN1QjI+bPatvxNYKt1I8cJt93PltzisJVZASPzoA7jwtri6bcK8u1nJyu9civWLTVtN1GxM9pPCt9KoUxxjGfwr5vaWRgmW3AVqaRrNzY3Uc1tKySp04oA9y0zSJLeS4juEdrZl3LFIed3+yK3dF06+fS1tlmEIT5gnmcj6GuM8E+KE1S8Q6xOov0GYi52q35cV0us3NxBIlykJiXOXKMCMD19BQBrPLFBbCRhdteo213AIzz6+lW7mR/sxezSZGK7pGDEn8+9T6b4g05rKI6g3lHaA425Galu5UuLErpUj2yscbnX5cZ96AIdMubKONRdPLcR8sVJOV9eKurPay3mcLNYMuMbOVNY9zd3VvZTvJZWnloh/eA5LH1qHQNSluLJ5rUxMc4CBcCgDW1GO1t4ydOthl1wxB2nHbNcP4g1pIYQ0cgcpkbUyRn61N4kGu3TLFCXzgsy8Ln6VyE1neNN9numaOIfe+cDr3oAi1W4F1ELq6SWTIO35MKp9q8+n+bUmlUExE/dzzXd+I5La3tRbpqJmIXAhHIAHeuJW/SCfMcY3+46UAdtp1zMlhFayQGzjlHy443/WsbX7l0ldE3bwmNp6fXNEWtzyoJrmYzOowhK4CU2RJtTjEpZAO5xzQBw9/hjgnDjqD1/Os7jv0rf16wa3kJwWY9awDjccdO1ADT1pp9ace9NJoAXtSd6B3oNACUA0p60UAGKKPw/SigANLzmnbTjODj1pvfigB6KwIOCcU+Yb2JQYPcVNCqImWYn1ApIo3kmLRtgKeaAIYjKp2pnnselNKsDhuDmt6XTfMthPbyox4LKOoqibVQwZmO/uD3/GgDPA+YZAxVy6t8Kvl45980y6KhtqrtI6d81EgJZWBOAaANbTWuBA0Qk+Q/wmqd7CUY52g56Comkk83liPpUkUDTOcN9d1AFq3eGRUWbcrjoe1ayzeZIuJBIqcZBxmsndF5wiZflAxk8kmrs0ETW5aDerg/N6UAaQvojMIzEC3AALcfjXT6PprXLA3IktIivymNMqwrioNN8lVMrYLDKn1rrLLXbi3txp4/eRL90ZoAY2jFbqSMec6s+coOD74rU0/T4ld4oPNWRmGYpI84PrgVNaahD5vmySNb3EJ+VEUlfxNbQ8RJ9hEotI57ndhpW+T8vWgCTwxAbW6ddSurcQNwpdOSfQV11h5sTM+mJaNARyXI/rXG6XbXFoy3hiEpkJYiTB2A+mTW3a2dub2V7tpPscoBVUf75+goAvu2kCZ5r26S0nJx5MZOM+vFQapc2a28ot5m1WSFPNn8pCRHGONzHoB061BB4ftdVvng8qVY4gWM0p8tQo5ZmbsoHU1Yvb601HQI/DGgpHaadBOskl2hCteBBwzr1BL/ADcknheh4oAy765trtI7aG2lhYDd5gi6nHQDvXOalYTvLF9oaZ2Y4VP4j+HaujknuneGwjmMMZBzISN5HqDWY7xW8sbyPIY4SWd0wC57Z74FACp4Ua00wXF4soU8lc8Vl2v2O2dj+9KBeEHVv8BXoel6rPqWhGRbWO4tU6+bwDiub1bVDm4LWVvbAqQhVuc9hQByhMGqXhMe2zhXjByQB647mr1tBa3F75VjKsmRsZ5MDj1ArFtrIwtI8zvEpBHXOSa6C00Y6bHHdSA+SxHlr1Yk+oFAHNa/ocWjSy/OJzJ8wAB4q1pAX7EDczSq7DCAA102vqFjgcjdM3UYrnrkwx2/2ky/vozuCBufpQBYh8Dy6hZy37MtraqcNLcDbkew7155rVhFFDJ9nmLwISAx6t+FdVqms3mopE8t0zRLwIiTtUfSsnVXt2tPJh28/M7lfmY/4UAcJ7kZ49aaeK0WsJVHmNGQuccjrUd9bmMKWPJ5oAoZ4ro/hr/yUjwl/wBhiy/9KErnP1ro/hr/AMlH8J/9hiy/9KEoA+kP2u/NWLwg8RwVnucn/gC14pZanJZBJJYg7EfK5GCte3ftcuq2nhUP0Mtz/wCgLXjvhU219YlL+MMgYkSZ5AoAt2N0usOfPjh3E7NgIDEeortvDKnTIHEjyxIG/dtJxXDvpttHc74t5jzgSdCDW7PdyTWBhC+cANrNux+dAHQrrz3bSwSTb5BwmTgH6VHeWFxIEkglWGQ8kI+VP1FUvDVrDJpbK0ciSqPlYnlffJrS0u6S3iuLQKsl7CPlkByGoA5TxbpIuImMcqyXIGCm3r9K8wv7WS3ZleN0PPUV9EaXbfaLrzZUtvNUZMMjbcH2NQ+LfB9rr+ky3GnWyR3SqchWHJHagD5tcDjggGmKxBO2tXWtNk069e2nVldDyDWYyEDJPJoAuW13IkqlWOR0Ir1Dwp4rgTy1v5yrkBSxO4fiK8gydx9vSrFvcPE5Ixg+tAH0jcXVlJJbXdjfR3qk/PFGoPbrj2rW1PxFHJCmnJNEjMOFdcY74NeI+DfGU2nXSxzhPs+3aVA6H1r1PRE0/wAWSmeC/tYb1fuRkgZGO+ev4UAbekX2nPbTxl0SYZVvnypPtnrXD6rO8WoMsEhiiB4O/bk+1dPeeGpoQ0txKyrGM+ZbgFfyrFi0aS4mjimDedJlo3cfL1456fhQBzWoeIbqDIS7cOq43dc+2axf7SumLJE5uCcl9w5/Our8Q+H/AOycHU0e5Lgn9wmAtULHSEEpu9PdDCww6yYyvpjFAGDb6eJhLJcsIzz8xIwvtXM3VksN3K3mbkOcFeeK7LxnZW9hAZYrvLsc+Xjua86lleW4+Utz1oA7DS1Q2A8xx5GOhUbmqzp8sM0ypZJIkSnJwPzrn7c+bsEjhUxgAtitm3uV0y2leFeZV25B4HFAGP4k3+a8kbgoMg5Oe9coc4JJPXFdXeyqts+YmdpOWZhj8q5eUcZIwDQBAaQ9RQaD1oAOopO9L2pOc0AH1pOlKetA6+tAB+VFN3CigCzBKY5FO3coPKnoa0Z7OG8dP7OBDkZZCfumsnvxVq1jmMoaFwHHvQA0iWzl/eIQ3T5h1q1YlryUqAit24xVy8S5a3BuVRx1yetMWxRbUXVpIuR95SeQfSgB8du9quCzBm4PpmoILZ7q72SNhx03Hg1ZtNVzB5E6owYYO4fdpgk2TEKyOOxx0oAjvdDvYDu2F1PORUFtDMism3a38q3M3hjEqEtH356/hWHcyE3DsHK8/doAuadCjyMt1EWYc8ckUy62RyFIvmLHqowB9aTT9RliJMJG4jDcdataVOn2kl0Lt22jkUAV9gj2l1Qj+9irlv5SS8hmjC5OQetaElgL2bzGkKr1CEc0TWKrGWLEFR0xxj3oAhtbufzGQxLKhHylh2rde5FtZhkWPzD1VAMge9c9ZQ3V9M0o4hjG0t0UVpaZA9peNJNE7LnhyMj9aAJxKlyYYo53jQ8ymQ9PpW/eLFZWcDRoJArA7t+S3uBUnhm0826e/e1iu1Y4WJsAj3rQW7aK8uYntbW1V/mG5d+foaAM+1vwuoRW9xdMICAXYgsSfTFdnpWnW8t9Fa2MjMJF3Rx7ueByxz91R1JPQVxugXF1Z3z3S6dbykE8sOB71u3GrRJBLHaxtE164a5aEfvGQdI8ngJn5iB1OM5wBQB0lrrNqzTaXC0l7YE/vpShDXLjpx/DEP4V7n5j2AwPEZtn3S6RY+XBbt++DHHzcZAx1qjq18suJYbto0HBUfeOO5xVrQNT2TvaQ2hnt2UNuVTwe55oAuQ2/wDaj2lxDdGEqu3lPug+prt4/AmjQeF7m5uPKa5kQnzRJnn615xrmrQ2weKLeiyKf3bAjcPrUMmvzNpkdrctPBaN/q492Sw9PYUAWLEraaa0SahILYMcqy/KTnsOtULOW3N/JJeiSVWBEcSpnf7n0rHa7mkjlV5hHEo2hUGTV/SJzpcYdCtzduuMDkIPc0AdHZ3lnbNiOMXVxMdio6fJDn2rqLnT7mPTlGbd51GUCvhFz1JrhBdLHFDPdyGFTz5ES9Wzzuat7S9Qhk80rI/kMu0qq5GPbNAHD6lq09tqht4ZEuTjDMq5H4Vjax57X0fmWxiQcnnrXXpplqZZZ7SFlljZtrbslvSpFifWBuuoVtooo8MXIyG9aAMXSNITULeWS7mS3tUONi/fkPoKy5tJNg7zNZMUJ/dqzctWzfG0to4ls7t3CnDCNeB7+9VJNVnkuCJ4ZHIGFTv7GgDF1uyjGyS5cl2UEKO3HSuP1a3w67G3Gu41Lzbl40uVwGHyohzk1zet6a9iXjnQqx5QZzge9AHKuCuQRzXRfDYY+JHhPkH/AInFlyP+viOse48sRqiId/cmtr4cIV+I/hMn/oMWX/pQlAH0v+1jD51j4Zx95Zrgjjr8i8V4xoTSaVYrcxoWAb95EV+Vxn17V9AftG2H2200BvMKeVLMcj3QV8+L+68xInlZWbae+SaAOvi1bT7+1KwoEyPmjf8AhPtVFP7Otoo5mQyy7/vLkAfUVVsdKkS0lF2EWNk3Rv8AxA1P4ejuFLQzRvcQMwG5ONvFAHYXyRvp6zW4byuMlT/KpbHTkng8yyVo7jAJDjh/cVmTW32F1aElgW2tDJ0xj17VfRWRoZljNuCM7S2QfcUAPudWW1It7zTxK8Zx5ida19N1eC/spXjjkhkxjYfb3qi+rRWym5VA7quMLyT9ataVcw3zLO8KwuwyQvcUAcDrHhQa9e3E0rtDMuQmVzu968r1rSZ9MuWjmUggcZHUeor6em0yC7Y73SHaOOM5FeeeOPDEV0G+yBpGQH5h83/6qAPEAMkbSOMU3GBnIrQ1LT5LSUxsBuHpVDaxOOuOODQAZO0AcH+dWLa5khKlHwQeO1VsfMMevelxgdqAOm07xbqViURLqbyVbd5Zc7SfcV3cHxl1EeULiytZvLwVVs4rx5T8vTPvT4n2NkgN7UAe4y/F631aSP8AtKwijjHGYpDnnrkYqpefELw7ZwKmj6Qd6k5Z5OP5V4xuBOQvTvTG55zzQB0XiTxVd63eNLNHEg/hCDhRXOqzGUEHnNNwaQ9celAGrEqG4VpQxjxgkd62YpYkCAKWiyDtZsc+tZi3GbFIxhQvJGetTWbO8KkKhXdjJoAt6rO2oHdPOePuqo4FYGowBIcmQ9OFrfvruRohGkKgIOStc3dwyKrPjIJ4zQBmmgDPNBPFJnkZoAXtSd6M8UnegA6UUUUAFFJ+P60UASqGLfKMn0FW7WfYCkyjb6moUV4JFkGCvqPSp76WOZQyEb+4PWgBJ3kaPKtui/lRaxsyHy9wJ68UzTYmnuFRT1IBr0zwzpGp20gijs4LqGQfLvAx+dAHmrRSq3Qg+tWbWSORtswKuTwQK9iXwVcamHRdP8i7Q48vgh/pXnni/wAJ32jXT+bBIo6/doAkgjdY4/s5Y+oI6iqF3pUshlKx8DJ3LVDTdRngYhXIwMbSeDWhY6u0EkjghWPYnPNAFGys2t5WdzkjjA60/wAmWJjPC5Ht3q9MGllW6dHUsfmPY1aFgwiYIFdm5ABxtoA0NFsWltDLchjI33W31Pf2SwWYE8iTo/OFbkfWsq4lmt5IwbhSoXpjpVjSruI3UhlkTa3XIz+NAE2kWS+SYVBXfltjNgGtiPUZbULayRRkgYG87hXMhPOufkn5UnaDnke1dBo0iw4+1rck5/gHUelAF+bUVn0oqkiQPHksIxjI9KbpEb3unXXnuqYwd0h6D1FQ3t2q7004ybXGPKaIc/jSbwthmWfyZ1P+qUZDc9KAE8OTK0rWt1K+1mIyDhWHvXRf2aBqiLYm3ICgu4bPA9vWsKVheGNXjhtyR8pIyfxq/oeor4fvTcRLb3G75cspJUeo9aANvVrKG702b7NbypPjLzMoGT3xWHoV7qNkwhWN44M7SyrlsZ7V0upXg1oE6c0yxFcvvG3J9q5uw1F9KuHtzGzqxxw3zH2yaAL3iKSE38IiQyzYwTIudoqG9eaeFckHaQqxrGDgVeuVluIpEeGCFmG4CN9zD6ml0+7igeP+05RBEBhogmS1AHOHT5rid47VJHJwXDYGD61ryaaE0OaOEbfK5aQnqR1BNaEl1HqrSQWaeRDuIJPyswpDey3lx9giijjt7cYKk53nHt1oAwNJuP7UxabP3jMBGW6KPU+1b2taWdKgBspZLp3z5wV/uj0HYVmXrwhJbaOLbcSHACsBt/KtC006bTbWO0kQXEkzhvMduAO+B3x70AR6VLeSOsNpaeVbEffwflPfk9TV97extLYwR7clt0ksrbnJ7kDtV3Vbi3cx29rNKkMP3h1LfQDisq6u4rUq0dsAHPzuwBYCgBdA0dJbm4+zRmO3AJWdxw30FU5dDDO4Zmfk5kchd3/1q77SltRpsUrviWXpBGMtj+lQeJlhtbWOX93Av+0KAPPVtIkIuNRMSW0LZQKvLEd6xdTWHWb2SRIzt7KBwfxrp7sy6jfoRE1wuOML8qj6VFbadPa3bmWRY7aPkrjHPagDzLXNFazQMqbd2cluv0FVfh4CPiT4Tz1/tmy/9KErtddikuJnMUInOTgZzt9zVLwDoU58deH7qdQNmr2RXAwP+PiMn9KAPoP9o+8t7aDw7Hdbgs0k4BBxghAa8e0dLL7C5WCQpISPmXqfXNeuftLWxuYfDaII2cSzlUc4DHYvGe1eRaeNRFs8TDyYUb5489PpQBPPBusHihS5x0UO2MH60/RYLvT5oQwVpWGXVCaddyTO0MUe145BhWd9pVv6UklpeaaIpgWW6XkgNuDigDodfga9gVfIwSM4J5NZFul9HbMTI0hX5U8xSxGO1bmmXZuZEGqmWLIG1zwM/Wti7Mdmim2QSL/EoPX3xQBzdjaanc3FldGOBY1P7xVP3+tdRFe6baXMazQlSxAKp1+tZzarHLKtpBG0VwVLIV+6KjfQNWubhbhZEU5BLnGaAN6+ntHdYkjcpn5HHHNVxBAnmC/c28oXhkX5SPWpdGsrq0u40vilxPknJxgj0rau4LfVreSGCJoJiCGKkfLQB5X4s8NQ3EEbRi2bzM/v2XBJ/KvLNa0JtORj5sTkE52GvcvF0E4t4ra5RRsB2uvJPGO1cRZ+F7a/0qSR5Ab1iT5DHBFAHkckTDB6gVG4AGBnOOa72+8PXccbQS2DrInt/WuTns1ikYS5XacDHrQBlgkH2NKvQ5x7VIyASkAf4U0oQRnp9aAGL05PFIT79ads5A559aYfvYoATOM5496TIOOOKfjHXFMwDnigCSDmVBngn862vtcdm+BHkEDvkflWIFPGOD2qymRIgkCyDg0AdpoN9bGJjNAjZPXZuP4VR8RXloQIxt3c5ygBplpqrWtqy2yeUzdNorGu7YuzTXE4dz0BOTQBhy7S+UHHvUZ7dKdISW/GmmgA7HPSk+lL29qTvzQAUUlAI54oAXNFJRQBsW93aPAUZTG/bPINZ06ASHb93rzU89rGsfmQPuHdTVdZMAq3PGMUAbfhS2ae4IEaSZ4Ck45r1vRbG6tbTZc70UfMqHBP4GvI/C8scN4C6tgddp5rudT8Qxm3jjjmkjkHcZH6UAdJ/aIh1MCe9mglUDDrIcCrc2tfa5UXVC19EoKiVPm3DvkVwOlypqN8yz3nku42hpBlTXT6Ro8lheBbmNpYych1baB9PWgDznxTpKx3kk+nrJ9mJJAZcFeelQ2Fh5kQmdWO0cFeefevZvFXhea60lpbS4hEWOUfCn868Yure60u5ZWDA56Z4NAG/ourbg9pL9mWIc/vUzkitXzY0hKxm3GMngEZ/GuJS7Ms43Rojeo4rct45YbdpGAbd1UtnNAEt0y3Q37ogRwGxzUX2ee1CSFQ0TfxADNWrGW2jxLNbsVXqg6fWpr6+jkspBaOnlnrGRyBQBItpbXVpG9u7Fl9RtA+lX4LHUJjEkbeWwz80j4GKwoJ3isgjI5X+EJ2PvU9rqE15NGt2ZjGg+4v9aANm7huYJVglvRI2clYxwB9azr3TbhYJJLaJygP+sLYFBu0a6Ah81FHHzDNWUvRY7jOgmhk+XJ6D8KAJPDdqbyQx3FykHmDKgcsfzrfvbE2KBY5omgj+bLEEt9RXC3968cxlsSzKme2MV0/hfW49SjRNRuvK8tOSI9xIoAvrqOpxSt9jkieGXgHaAPwras9L0xmkm1GV5nCF5GHQH0rB1VJpbcSQ2zuckxyoAFZfcetYd9q18kEdtFEI4Bw4Qkn8TQB1NkUS5uk0/ItWGWdeTj61k37QTShVuCig+5Yn1qtp2uYh8m3gKOOWOcA8VTsdbae/wDInghLMwVGKjigDo9IjtLqPyWvliQdW5GKs6LFbWJuhH+/keTETvw236UXGm6Zp9oss9ws00p4VByT/hVew1LT7a6kuJ2mbICiNOaAOgtoLS6t8TC2sUjYtvYfMx9vWpdMu7dZmitp0kZ2ILvyT7ACuG8R6xZy3CRWnmRox3MW+c5rofA3zWxlcNEd3ybI/mPuKAOito5bS4eBLUPcufkZwcYrFvIhYRyfb7uKZi5MkgXd/wABHvXTRXNzYJMJjEvmLtWWV8yH047Vhy2KNHh777TPkuIYgAAfc0AP8K6pHJdFbISRRJnzCF5I+tReK7mbWbmCS0tJbi2jJw3TBrovDtpG9s8d1ClvAowIoW+aT6mrWqQzXjRWmnypaW4wG8sZYD2PTNAHniS6xbKEiWNCSVWNf6mqeoatcwwvbSxqSvLyt0HuK7fVdP0nTFKQzzSSgDzJSchfqa5LXE07yR9mjlmc5IZhwfQgelAGTpeowzolhbKR5jHJUfNITXpeiaALHV9Dur148/bbby4hxsPnJjPvXmnhaKHTtQkur5/JjOdqqu6Rz6D0rttIubvXvEuiERSeTFqVrIsXXYqzocsfXAoA6H9qaCaZPChgz8k1wTg/7C15loqCbS18zUPMCPuKDqPY+tey/tCWUV6vh0SOVdZJ9g3YByi5Bryw2dqumtaNbyQ7QfmX+eaANS3gtZJAkkccqSgAFSee3FbFn4dIiY2+2XY3yrIxyntmuO04zJBBJaTpK8bZCMOQK9G0O5GoWbR3btDOP4imw5+negClqGlTXNmPtkCLECOjcjH0rObw/dNcx3NjdrPDGP8AVk5OD7VqXlrexpPGshbIwBjtWTZ3LSQz2qp5VzFxuB2k4oA6GGCC8hWJrZI5QMFuh/xqxqM4tIEgt/3bAY+aTg/nXI22qXv25IZldmPBkRC22unudAW9sWlmmeSfblSrYXPbigCgbS91C/tEEpjQ/eljfgL9a3rjT4dMlhjkui0cxwTu+b86yLa4m0qeG2YRTRkjO0Y2/jWnqj24EU81szhe2en0oAxPEmnXT3klrpq7gI9xeQ5HPp71S07SXsbYHVoS3ACzrkEe3FdcwXULiNogYto5IP3h707xDYhLFEinckkHaO9AHM2zNJp8yWzLMRnaGOWYfjXGaj4R0zUJpmltp7RzyzMxIB9eK9CsfD5XDIrgcksG60j2kkZZ4FdiRiRJRQB4FrvhQWd6Vs5Bcwj+NO1c+2j3LnEcLsMn7o617pq1tDbf6RNE2G+8I48ge1WNOuNMaxdIrEwxZ4d1PXHWgD52ubSWGQLIrKcdx1qtsYE4B5PWveJPCdi7GXUJY5i+SpLAYFchqfg2BrVpLScvICTjPGKAPN3hdcZHHr2qUWExCnbnPStSa3I3RbSChxx6iun8E6RJLIszhDtGQswyKAMvR/Aes6jAk0dnIIX/AIyQBj1610mi/DgvKPt91DDCh+b5uTXpNve3H2MhbiyVFG3YiYH0BzWHftNMytYSwrInL5OQaAMvU/C3hOzt9h1ALP2yx/wrzrxDDZ26mKxy5GfmHOfzrqvF0d/dKr3BhUL91Y8Fvqa5C8gmhYPMShJyQelAHKyxyJncpAznmoPWtm9VZkJUkkH7x4H5VjsME9eOKAE/hNJ3pe1J3oAKB0ooYjGMUAFFJuHrRQB2epW+mCLo8MvcDlTXOXdn5coCEkH2rTvNPu5YzMhMkXU7DnFV9Ollgk3Oqvg42sMigBbKEwyAujAnrxXYaCml3V/CmppI1mTg7eq/41T/ALQsJI1Y2pguF7oflP4VtWWq6K1ptms8v/fhbaR+BoA9c0D4a+EdWSNNLu2MjKGAckHJro/+FcT6Ra+X9rSSI/d3jIBryvw94jvgYoLKRHj4GyQAOPxFegaT4k8RiBoJpvtadQkpAYewJoA5bW7LVEklsp0UxZ+SQHKn0HtVnTtAhvLQHWdPN6iDHDDcPpjrXa3mty23kzXNpFcQkZdXIBH41PrviDQNR0sxQ21xYXLDCSxD7v5daAPAfHXgOKEPfaJHOLUH5o3Byv09q4gOY4WB80SqQBX0oJ7ldI8out6hBwQhz/8ArrxHVjImoXMU1tHkscrtIxzQBm6PI1zGiztt3fLubpVnxF4WvdLUXYKSW7d0OfxxXpvhyy0258PeVNZ2gAGC4+8DXNa9e/Z8WaSjyQQG+Xkj0oAq+EollsGkN5EAo+6EG6s0NI19KJRJwxAZVAJHvU0sukSFItOM0E4I3sx4PqBVTUYLhJlYyZjB7ck/lQBW16NI5bZoFkx5gDF+OPSodYZ44UMLqQSNwXpUF5fuJTG4JH8Oeea0LJXntGNwiRqDnPQCgCpZak8lu0FrBGpJIZmGSam0/T7p5kkMkcZBwBuGPyp+nxSW08n2dVaA/wAWO/tUs979jRfLiXzC52t3BoA2tS1O8ito7GaQIqjCmIdR71TFuhjgtUb95OCxZiRn60+11ACNROizyEdGXcwz6YrN1lluWQWW9JAcEHIxQBLe262UgjimLS9/L5FUbK2na8AYIwzndjkfjUVvp0sdwhe4J3H5+cYHrW9fWcdlDF5MVwxzy7cKR7UAX5LGS5sy8bgRxj5izY/Wufvy0gDhiFUYCqetWZIri6t0MUo8rP3eg/Wrln4dkMv2m8kRYsYwG6+31oAzLWKNZ1VnWWYgEDdhVr0nTJreHSsRSTXE6gAqjjA/Gsa90LQLGz824mP2qQZWOMZNRaBqWnQ3DobdI40IJEjE5/LvQBqaHEtxq06zHz/Kbequ+Vyf51rypJbxySzzw20YPIjTBPtVrR4LYal9rnjiSN13RrGm0Y70zVLkXt+0VokIt1G3Ock+5oAl02SN0Bgm87PPlx9vrUOoeKZLeTyMIOwji52Z/vEd6jihvLHTbiF1htkk6yIeSPf3rl/srWTTNBMzRNyxYHcaANjX576XTeAq2qNuZwcA+xrjbCHWdT1NkgjkeVj94Dov+Fev+EPh5deJbeCXWb549PXDpbxjBavWodD0vQtNZNOtIYnC4DlQWJ9STQB4FZeG7q32wtGizMMyTyDkCuw0WW30e60mzsmUtLe26u23LSZlXJ+mDVzXpLaxhmvNav4IYAD1Iy30FeXad8RtNfxZoOnaLHJLdXOr2cT3Mo6RmdAQo+mRQB6f+0dN9n03RJASGEsuGHUfKK8/09optNjmubkhWXIfA/Wu2/aWuxaw+GvkDs00+Ae/yLXB+F7i0vbbyp1MO/IG35gD60AWRYxGL7THtEijKyR9yOmaVjrOqvAltcxJJHgnC9astb/Z7uNEbzbR+A6jbtP0qeO0uLG6bbgqxBV4x/SgCxdJqYCw3YDAfMNvVvxqrcWizvuiW4ikGN27AzWnBeXErbNQwLcjhgSCDVC+jMWqAGdjCVzHI7Zz7UAT2sk9pKIoREzcHa3Gfqa0xLNd3Me3fDG2BtzgUumm28tV8sPcAE7kOf0pLPUVjDnU1VGViuc4wD0yKAND+y7d5R9qCyMBwSRxWTfSW8d3NG8zGHbt8snp9KsG5SW6P2gKYDzEyDIIqneabazQi4so5wM5fcMgY70ANs9MeWbzYLx8IOEbgiteObULyJopIbcxg/xZBqfRI5pV8zzoyAP7vP0qwvkRXTyy3K7m42npQA3TrV4YvmacxgcqhBq3JbRXsDRxjySR13DdTINZjtW2RgBTzkjINRXiLMDcyXarDnJCUAVpbSRbeWF4bcgggMT8x/CuJu47rSbp4Le0S6aQ5O852/hXWyWV1dXKXNnEfKiHDvUEkD+WZVZGOSHkH3qAMSLQJby1Mk8KJJj5tp/lmscwaa4e2htm87pnJrtLG7snmeLdcGRVyFzkGmXFt9vt5H2Cz8vJBU7jj3oA5K08GaUsD3F28CKTll3AnNbOi+HdOLILNWW2bJbcKoadp1tpxN3eiO8bfuQn5Tz612FvcXGp6aWgt/KP8KsfloAqagug2ttJbKnmuo5RAOTiuAS5td0ti0OxmBIJ4PNddGyTSvFHZhJlO0sgyAe5rO1fV7LRUWK4gFxcuD1GMA0Aeb+KgLO5X7KgaQDnBJCj0NcXqM8l0D9obc/ZR0Fdv4ouZppfMjhS3imHK7utZNrbzyQuAkaR5+aRhQBw0cio2yUD6VUuAC7eWmBnNauqWflzq2flLcE96pXheOEBcBSccUAZ+OKTjPSnYyppo60AIOfY+lFKackTuCUXKjv2oAbn/ODRRtP96igDcsr6S2hH2eUgN1GeDU0Tq7blO7nJ9c1zpapoZmQZGaAPRNDv7Vk8u8SF065cYNX7+z0mFVlt0jYnqqvXmsN7KpLN8wxjFaukNPez7UPHv2oA9W0fw2msafuspPImAyvzA89hUsOkazpjlZ5yVVsZD5/Q1k6Xe3ei24SVMAgbXRuRVC48QNcNMl9LOxH3X3fzFAGx/wAJLfxTCC5l+0wbipTGCa9F8IraXCslusUZAAKlzu/WvHtM12CKUyS2sd1GTjLjBrttE1zTbwhltJI3AwdrdKAOt1u+k0ASCxM8U2N3zfOr+wHrXlfifWLzUJhNeJGkx/iVNjGtzWrkTFhBK567WlyStefahPeve+ULgyIh/i7fTNAF6LULkEL5sgQjsetQSXEhuWJBkAPO8cCr0hxFEfl8zGCQKnP+ixqbhI50fGBjB/GgBNEsbfU5D5zKh6fJ1rY1a1l0RYvs8odJONu0E/iazdCeC3vHbPzHsFrutK1PTrnd9otGlCjgMBj60AUtC0PSdaUHWohC+eBAAM/jWb4r8C20To+kSXKxcf63kda6m71HTrhXWzh8qRB8oVdvNYz6Re3tqWiu3EYIYhzn8qAOD1HTWsCYJJmY442nvWc9rIsI8yORm6jArv2nbRlZprSGZweHYA4FJc+J/I2SpaLkqclQowfpQByGly21qqtcm4gYddmN361oILR5A9rLNErZJkmwc10NnqSa9bGO5tLZRFz9zLN+NDaRZToPPX7PCCRhCSaAOXlNqYJYEdN5cN5zcY+tVb+6knUBr5X2jaq5OfwFdjBpHhuW6VW+0G3/AOWjk8j6DFbWreHvBS6az6ZBdyzqNyncVz9c0AcTpmyysluNRkg2v92Lq/4+lZ2t6ktzMq6crbF5PXCn2pbjQpZF8xQoWNjwWzn61ZsNB1Ca0Etv5G1sjHSgCCC21Gf94MPGRlnY8itqHT4kt/tBk2omG2KMs5rmrqy124YxxMAifLhXAAHsM1T8/VLWQ28z/N3w2T+dAHff2lqVxcpHYRbgRwcZ211kKixsohPbxo5GS5Hzufas34aeFfEmsIotJLa3t2+bzXOcfQV6mvhrQfBqDUfFmpSXrYwm+Jiqn2C5/WgDmtP0rUdZh220DyK/baPl9yTXV6V4As47dW1YpCF5Ckgc+tcV4p+Plhp0TW/hqwKhRhXlTaB/wEV4T4s+JniDX7lpLm+lAycIhKqPwoA+qtU8YeDvBVgY47/zp14CxHey/wBBXiXjT47X1zdTLoq+XERgPL8zfl0rw26vZrhiZJGb6mqpbOaANjXvEWpa1cvNqF3LM7HJ3NwPoO1Wfhuc/Ebwn/2GLL/0oSubPtXR/DX/AJKP4S/7DFl/6UJQB9g/Ha2trtNBhugCTLMUB9dgrzTTvDdraOZUIAbGY3yPyNem/HYW722iR3PAeWXDAcj5R09K4GzslubQW8crzRkYUyE5z9aANrTreD7N5UxfysEBW5wPrUMml20yeXZ3oR0OQrHvT7NL2ztDB9nikXkKJGBP51Fbw5LRXtlEXJ+XDZA/GgCn/Z+sz5iv2Ei54welaraNc2Nh5tlKrsR9yRc4zWDPLdaXfhXlkVc/KhYuD+Oau/8ACS3AMUNwVjLHahwWB+uKANDSNO1Q4nlWCJxyu1DzW5FJBewlJ9PEkqcO7Y6/SktdQvRbnGx0K/Jjofz6UCSZlhnu4lt5GbkodwI96AG6jFELXZHGYZV5QKODjoKowDUbqSITyCMr1CAgHPqO9a0VtDJcrLLK0voDnj6VonZZxmT5mj6gjGRQBys2nzfaxJHFLGVH+tQ4U89CK0YbCCGLzNRbeX6YH86m0+5g1SWeJp5nx8wU8AVPctEmy1VmaQnpJyoGKAKMenJb7LpW2Wq8sTyCPanzaO01+s9oY3UpgA9Prirk6XzPCLQQtGoJMZPyMPoa6GzXfbfv7dY3xz5ZFAFa1vRbWRtri2lL7SoZBkGsa2iRbeRbiGSEZJBIFaV+piJMEzIR1Uk8/jVOWG8uI2MkUZU8D94aAOTluEj1Fhb20s0YX7wIBHvWn4a09ZGuTNK6gtyjDoKt2ds9rP5hijRmHLdTT2vJ3kkELrhuhK4NAFC4Wz0668hYvtZAO0BcYqGIQ3E3k4njkYZ2kYX8Kt3V69hb/OgY5xuPzHmo7a8t7i4juZ4SJUUj5Tx0oAjvbW3sYtvmSszdVQY/WuCvoJ/PkWzcF3yd8nJFdV4k1K6vAyRJiALxtIUmszQ40+yGW4h2g5JVsMaAOOutHvbVJJ7li+RuyFzWHeWMVvZK8tw0kvUEDk57Gu88SziaMJAXYg9On51yupaTPlWupIkDfwpkgUAcJfWE8xE8oRE7Amuf1KRX+RVIxxn1rv8AVtOhKtFD5ryDBLO2AB9K5u4S3tkK+X5jg/ebpQByToyg5zio+OTWzc7rgMwRQmeM9qypU8tyDjPtQBFnn9aeZWZcdF9qbmmg8GgA/H9aKXn3/OigD//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Sagittal transvaginal sonogram shows endometrial polyp (arrows) in fundus. Endometrium appears thick and is difficult to measure. (B) Sagittal sonohysterogram shows single round 1.9-cm echogenic polyp (arrow). Note otherwise thin endometrium (2 mm).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Joizzo, JR, Chen, MY, Riccio, GJ, Endometrial Polyps: Sonohysterographic Evaluation. AJR Am J Roentgenol 2001; 176:617. Copyright &copy; 2001 American Journal of Roentgenology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_28_450=[""].join("\n");
var outline_f0_28_450=null;
var title_f0_28_451="CT scan bile duct stone";
var content_f0_28_451=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F64701&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F64701&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CT scan showing definitive distal bile duct stone",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 287px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of ML Freeman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_28_451=[""].join("\n");
var outline_f0_28_451=null;
var title_f0_28_452="Bullous pemphigoid on lower legs";
var content_f0_28_452=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F71249&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F71249&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Bullous pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Tense bullae on the anterior tibial and ankle skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_28_452=[""].join("\n");
var outline_f0_28_452=null;
var title_f0_28_453="Interictal PET scan";
var content_f0_28_453=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F75459&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F75459&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 535px\">",
"   <div class=\"ttl\">",
"    PET hypometabolism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 515px; height: 298px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An interictal PET scan after intravenous injection of Fluorine-18-fluoro-2-deoxy-D-glucose (FDG), showing left temporal hypometabolism, medial more than lateral (see boxed area), but extending to the insula and possibly to the parietal region.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Figure courtesy of Hiba Arif, MD and Lawrence J Hirsch, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_28_453=[""].join("\n");
var outline_f0_28_453=null;
var title_f0_28_454="Lactational mastitis";
var content_f0_28_454=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Lactational mastitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/28/454/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/28/454/contributors\">",
"     J Michael Dixon, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/28/454/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/28/454/contributors\">",
"     Anees B Chagpar, MD, MSc, MA, MPH, FACS, FRCS(C)",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/28/454/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/28/454/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/28/454/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/28/454/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/28/454/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lactational mastitis is a localized, painful inflammation of the breast associated with fever and malaise that occurs in breastfeeding women. Management of lactational mastitis will be reviewed here. The management of a breast abscess and other inflammatory breast disorders are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/17/9495?source=see_link\">",
"     \"Breast abscess\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43991?source=see_link\">",
"     \"Breast cellulitis: Clinical manifestations, diagnosis, and management\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/53/857?source=see_link\">",
"     \"Erythematous disorders of the breast\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lactational mastitis has been estimated to occur in 2 to 10 percent of breastfeeding women [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/1\">",
"     1",
"    </a>",
"    ]. The risk of mastitis requiring hospitalization is much lower. In one retrospective study, 127 women from a cohort of 136,459 new mothers were hospitalized for mastitis, resulting in an incidence of 9 per 10,000 deliveries [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who develop mastitis while lactating usually have breastfeeding problems (",
"    <a class=\"graphic graphic_figure graphicRef68275 \" href=\"UTD.htm?6/27/6579\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/3\">",
"     3",
"    </a>",
"    ]. Risk factors for lactational mastitis include an episode of mastitis with a previous child, severe prolonged unilateral engorgement, poor milk drainage and nipple excoriation or cracking [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/4\">",
"     4",
"    </a>",
"    ]. Organisms gain access to the stagnant milk through the nipple and this results in mastitis, which, if left untreated, can progress to local abscess formation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=see_link\">",
"     \"Common problems of breastfeeding and weaning\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/17/9495?source=see_link\">",
"     \"Breast abscess\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS AND DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of mastitis is made clinically. Lactational mastitis typically presents as a hard, red, tender, swollen area of one breast associated with fever &gt;38.3&ordm; C in a nursing mother. Other systemic complaints may variably include myalgia, chills, malaise, and flu-like symptoms. In the early stages of breast infection the presentation can be subtle with few clinical signs, while patients with advanced infection may present with a large area of breast swelling with overlying skin changes (eg, erythema). Reactive lymphadenopathy can also cause axillary pain and swelling. Septic shock rarely occurs.",
"   </p>",
"   <p>",
"    In a lactating woman, severe engorgement can be distinguished from mastitis because engorgement is bilateral with generalized involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Laboratory",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory tests are not needed for the diagnosis of mastitis. If the white blood cell is markedly elevated with a marked left shift, streptococci, particularly Group A streptococci, is more likely to be present. Culture of the breast milk is useful when the infection is severe, hospital acquired, or unresponsive to appropriate antibiotics [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Blood cultures are of little value unless the patient appears septic.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging is useful if lactational mastitis does not respond to supportive care and antibiotics. Ultrasound is the most effective method of differentiating mastitis from a breast abscess and also allows for an abscess to be drained with ultrasound guidance (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62711 \" href=\"UTD.htm?31/34/32288\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/7-11\">",
"     7-11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/17/9495?source=see_link\">",
"     \"Breast abscess\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Magnetic resonance imaging (MRI) may be of value if inflammatory breast cancer is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/20/31048?source=see_link\">",
"     \"Inflammatory breast cancer: Clinical features and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Plugged ducts",
"      <strong>",
"       -",
"      </strong>",
"      Plugged ducts are localized areas of milk stasis with distention of mammary tissue. Symptoms include a palpable lump with tenderness. They are distinguished from mastitis and breast abscess by the absence of systemic findings. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=see_link\">",
"       \"Common problems of breastfeeding and weaning\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Galactoceles - Galactoceles (milk retention cysts) are cystic collections of fluid, usually caused by an obstructed milk duct. These present as soft cystic masses on physical exam, but are not tender and are not associated with systemic findings. Ultrasound may show a complex mass. Diagnosis can be made on the basis of the clinical history and aspiration, which yields a milky substance. Once diagnosis is established, excision is not necessary. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=see_link\">",
"       \"Common problems of breastfeeding and weaning\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Inflammatory breast cancer - It is most important to ensure a patient with a suspected breast infection does not have an inflammatory breast cancer. In inflammatory breast cancer the skin examination will demonstrate thickening, erythema, peau d'orange, and there is often associated axillary lymphadenopathy (",
"      <a class=\"graphic graphic_picture graphicRef65383 \" href=\"UTD.htm?0/34/545\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/20/31048?source=see_link\">",
"       \"Inflammatory breast cancer: Clinical features and treatment\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most lactation associated breast infections are caused by Staphylococcus aureus. In one study of 127 women hospitalized for mastitis, methicillin-resistant Staphylococcus aureus (MRSA) was the most common pathogen from cultures of women with either mastitis alone (24 of 54 culture specimens) or those with mastitis and abscess (18 of 27 specimens) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/1\">",
"     1",
"    </a>",
"    ]. These results and other reports suggest that MRSA has become the single most important pathogen in cases of lactational mastitis [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/53/8026?source=see_link\">",
"     \"Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Less frequent pathogens include S. pyogenes (Group A or B), E. coli, bacteroides species, Corynebacterium species, and coagulase negative staphylococci (eg, S. lugdunensis). (See related topics).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The guiding principles in treating lactational mastitis are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Provide symptomatic relief. Anti-inflammatory agents (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/38/15978?source=see_link\">",
"       ibuprofen",
"      </a>",
"      ) along with cold compresses or ice packs reduce local pain and swelling.",
"     </li>",
"     <li>",
"      Improve breast feeding techniques. Continued breastfeeding should be encouraged; treatment does not usually require cessation of lactation. Breast emptying is essential throughout the course of treatment. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Role of breastfeeding'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Treat with appropriate antibiotics; probiotics may be a useful alternative to antibiotics [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/7,14-19\">",
"       7,14-19",
"      </a>",
"      ]. A randomized trial of antibiotic therapy versus breast emptying alone demonstrated faster clearance of symptoms in women using antibiotics, although milk drainage alone relieved symptoms in some women [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      If the patient does not respond to symptomatic relief, attention to breastfeeding techniques and antibiotics within 48 to 72 hours, evaluation with ultrasound imaging and referral to a breast surgeon for assessment of an underlying abscess should be initiated. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/17/9495?source=see_link\">",
"       \"Breast abscess\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Antibiotic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Empiric therapy for lactational mastitis should include activity against Staphylococcus aureus:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the setting of non severe infection in the absence of risk factors for methicillin resistant S. aureus (MRSA), outpatient therapy may be initiated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?3/11/3253?source=see_link\">",
"       dicloxacillin",
"      </a>",
"      (500 mg orally four times daily) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/37/37462?source=see_link\">",
"       cephalexin",
"      </a>",
"      (500 mg orally four times daily) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/14\">",
"       14",
"      </a>",
"      ]. In the setting of beta lactam hypersensitivity,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      (300 mg orally four times daily) may be used.",
"     </li>",
"     <li>",
"      In the setting of non severe infection with risk for MRSA (",
"      <a class=\"graphic graphic_table graphicRef53504 \" href=\"UTD.htm?5/9/5275\">",
"       table 1",
"      </a>",
"      ), outpatient therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      (1 to 2 tabs orally twice daily) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"       clindamycin",
"      </a>",
"      (300 mg orally four times daily) may be initiated.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"       Linezolid",
"      </a>",
"      (600 mg orally twice daily) is also acceptable.",
"     </li>",
"     <li>",
"      In the setting of severe infection (eg, hemodynamic instability, progressive erythema), empiric inpatient therapy with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"       vancomycin",
"      </a>",
"      (30",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      intravenously in two divided doses every 24 hours) should be initiated; therapy should be tailored to culture and sensitivity results. Gram stain results demonstrating gram negative rods should prompt empiric antibiotic therapy against these organisms with a third generation cephalosporin or a combination",
"      <span class=\"nowrap\">",
"       beta-lactam/beta-lactamase",
"      </span>",
"      agent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The optimal length of therapy is not certain; 10 to 14 days is likely appropriate to reduce risk of relapse. In persistent cases, a mid-stream sample of milk should be cultured and antibiotics tailored to culture and sensitivity results. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Microbiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The probiotics",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/16/32004?source=see_link\">",
"     Lactobacillus",
"    </a>",
"    fermentum and Lactobacillus salivarius appeared to be as effective as antibiotics in a randomized trial of 352 women with infectious mastitis during lactation [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/19\">",
"     19",
"    </a>",
"    ]. However, the study was not blinded, and the findings require confirmation by others.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Role of breastfeeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Milk drainage, either by breastfeeding or pumping, along with pain control will help relieve the patient's symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/5,6,8,14,15\">",
"     5,6,8,14,15",
"    </a>",
"    ]. As discussed above, a small randomized trial showed that emptying of the breast resulted in a significant decrease in the duration of symptoms and a significantly improved outcome in cases of lactational mastitis [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women should be encouraged to continue breastfeeding following the development of significant breast infection, even following mini incision and drainage. If the incision does not interfere with latch-on, breastfeeding may continue on both breasts. If there is difficulty with breastfeeding because the incision interferes with nursing on the affected breast, the infant cannot relieve breast fullness during nursing, or there is concern about spreading infection to the baby, hand expression or breast pumps can be effective for maintaining the milk supply until the woman can start breastfeeding again. Nursing should continue on the unaffected breast. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=see_link\">",
"     \"Common problems of breastfeeding and weaning\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Rarely, women present with widespread nipple excoriation and whole breast involvement who are in obvious pain and significantly disabled by their infection (",
"    <a class=\"graphic graphic_picture graphicRef76043 \" href=\"UTD.htm?9/21/9555\">",
"     picture 2",
"    </a>",
"    ). Such women should be advised to consider stopping breastfeeding so their breast infection can be controlled. It may be advantageous in these women to suppress milk production using the agent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/2/7206?source=see_link\">",
"     cabergoline",
"    </a>",
"    , 250 micrograms given twice a day for two days [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/7,20\">",
"     7,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H192787542\">",
"    <span class=\"h1\">",
"     CANDIDAL INFECTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Candidal skin infections in lactating women are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=see_link&amp;anchor=H14#H14\">",
"     \"Common problems of breastfeeding and weaning\", section on 'Candidal infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     RECURRENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent mastitis is uncommon but can result from inappropriate or incomplete antibiotic therapy, or failure to resolve underlying problems in lactation management that interfere with complete milk drainage.",
"   </p>",
"   <p>",
"    Mastitis that recurs repeatedly in the same location or does not respond to antibiotic therapy may be inflammatory breast carcinoma. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/20/31048?source=see_link\">",
"     \"Inflammatory breast cancer: Clinical features and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of developing mastitis can be reduced by frequent complete emptying of the breast and by optimizing breastfeeding technique [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/454/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=see_link\">",
"     \"Common problems of breastfeeding and weaning\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/26/3491?source=see_link\">",
"       \"Patient information: Common breastfeeding problems (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?36/61/37845?source=see_link\">",
"       \"Patient information: Common breastfeeding problems (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lactational mastitis is a localized, painful inflammation of the breast that occurs in breastfeeding women. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lactational mastitis is usually caused by breastfeeding problems. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mastitis typically presents as a hard, red, tender, swollen area of one breast often associated with systemic complaints including fever, myalgia, chills, malaise, and flu-like symptoms. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations and diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ultrasound is the most effective method of differentiating mastitis from a breast abscess. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations and diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most lactation associated breast infections are caused by staphylococcus aureus. Methicillin-resistant Staphylococcus aureus (MRSA) is becoming an increasingly important pathogen in cases of lactational mastitis. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lactational mastitis should be managed initially with systematic emptying of the breast, anti-inflammatory agents and symptomatic treatment to reduce pain and swelling. If symptoms do not improve promptly, we suggest treatment with appropriate antibiotics (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that breastfeeding continue during treatment for lactation associated breast infections (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). If there is difficulty with breastfeeding, hand expression or breast pumps can be effective for maintaining the milk supply until the mother can resume nursing. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/1\">",
"      Committee on Health Care for Underserved Women, American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 361: Breastfeeding: maternal and infant aspects. Obstet Gynecol 2007; 109:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/2\">",
"      Stafford I, Hernandez J, Laibl V, et al. Community-acquired methicillin-resistant Staphylococcus aureus among patients with puerperal mastitis requiring hospitalization. Obstet Gynecol 2008; 112:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/3\">",
"      Dixon JM, Khan LR. Treatment of breast infection. BMJ 2011; 342:d396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/4\">",
"      Foxman B, D'Arcy H, Gillespie B, et al. Lactation mastitis: occurrence and medical management among 946 breastfeeding women in the United States. Am J Epidemiol 2002; 155:103.",
"     </a>",
"    </li>",
"    <li>",
"     Department of child and adolescent health and development. Mastitis: Causes and management. World Health Organization 2000. file://whqlibdoc.who.int/hq/2000/WHO_FCH_CAH_00.13.pdf (Accessed on August 17, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/6\">",
"      Spencer JP. Management of mastitis in breastfeeding women. Am Fam Physician 2008; 78:727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/7\">",
"      Dixon JM. Breast abscess. Br J Hosp Med (Lond) 2007; 68:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/8\">",
"      Prachniak GK. Common breastfeeding problems. Obstet Gynecol Clin North Am 2002; 29:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/9\">",
"      Berens PD. Prenatal, intrapartum, and postpartum support of the lactating mother. Pediatr Clin North Am 2001; 48:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/10\">",
"      Kvist LJ, Rydhstroem H. Factors related to breast abscess after delivery: a population-based study. BJOG 2005; 112:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/11\">",
"      Dener C, Inan A. Breast abscesses in lactating women. World J Surg 2003; 27:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/12\">",
"      Renz DM, Baltzer PA, B&ouml;ttcher J, et al. Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study. Eur Radiol 2008; 18:2370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/13\">",
"      Schoenfeld EM, McKay MP. Mastitis and methicillin-resistant Staphylococcus aureus (MRSA): the calm before the storm? J Emerg Med 2010; 38:e31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/14\">",
"      Jahanfar S, Ng CJ, Teng CL. Antibiotics for mastitis in breastfeeding women. Cochrane Database Syst Rev 2009; :CD005458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/15\">",
"      Thomsen AC, Espersen T, Maigaard S. Course and treatment of milk stasis, noninfectious inflammation of the breast, and infectious mastitis in nursing women. Am J Obstet Gynecol 1984; 149:492.",
"     </a>",
"    </li>",
"    <li>",
"     Dixon JM. Breast infection. In: ABC of Breast Diseases, Dixon JM (Ed), Blackwell Publishing, Oxford 2006. p.19.",
"    </li>",
"    <li>",
"     Dixon JM, Bundred NJ. Management of disorders of the ductal system and infections. In: Diseases of the Breast, Harris JR, Lippman ME, Morrow M, Osborne CK (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2004. p.47.",
"    </li>",
"    <li>",
"     Hughes LE, Mansel RE, Webster DJT. Miscellaneous conditions. In: Benign Disorders and Diseases of the Breast: Current Concepts and Clinical Management, Hughes LE, Mansel RE, Webster DJT (Eds), Edward Arnold, London 2000. p.231.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/19\">",
"      Arroyo R, Mart&iacute;n V, Maldonado A, et al. Treatment of infectious mastitis during lactation: antibiotics versus oral administration of Lactobacilli isolated from breast milk. Clin Infect Dis 2010; 50:1551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/454/abstract/20\">",
"      Rains CP, Bryson HM, Fitton A. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation. Drugs 1995; 49:255.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 798 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-180.241.123.62-BF10BB01C4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_28_454=[""].join("\n");
var outline_f0_28_454=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H15\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS AND DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Laboratory",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Antibiotic therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Role of breastfeeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H192787542\">",
"      CANDIDAL INFECTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      RECURRENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/798\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/798|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/34/32288\" title=\"diagnostic image 1\">",
"      Ultrasound appearance of a breast abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/798|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/27/6579\" title=\"figure 1\">",
"      Common sites and types of breast infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/798|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/34/545\" title=\"picture 1\">",
"      Inflammatory breast cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/21/9555\" title=\"picture 2\">",
"      Extensive lactating infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/798|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/9/5275\" title=\"table 1\">",
"      Risk factors for MRSA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/17/9495?source=related_link\">",
"      Breast abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43991?source=related_link\">",
"      Breast cellulitis: Clinical manifestations, diagnosis, and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/15/17658?source=related_link\">",
"      Common problems of breastfeeding and weaning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/53/8026?source=related_link\">",
"      Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/53/857?source=related_link\">",
"      Erythematous disorders of the breast",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/20/31048?source=related_link\">",
"      Inflammatory breast cancer: Clinical features and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?36/61/37845?source=related_link\">",
"      Patient information: Common breastfeeding problems (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/26/3491?source=related_link\">",
"      Patient information: Common breastfeeding problems (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_28_455="Prenatal ultrasound images of single umbilical artery";
var content_f0_28_455=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F73747&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F73747&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 606px\">",
"   <div class=\"ttl\">",
"    Prenatal ultrasound images of single umbilical artery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 586px; height: 336px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (Panel A) Single umbilical artery. Transverse section of a two-vessel umbilical cord in two different fetuses shows the typical \"soda can tab\" sign.",
"    <br>",
"     (Panel B) Single umbilical artery. Longitudinal views of a two-vessel umbilical cord as depicted by two-dimensional ultrasound show the single umbilical artery (sua) and the vein (v). Upper panel, fetus with a coiled umbilical cord. Lower panel, fetus with a straight, non-coiled umbilical cord.",
"     <br>",
"      (Panel C) Single umbilical artery. Color Doppler ultrasound shows a straight, non-coiled two-vessel umbilical cord (upper panel) and a coiled two-vessel umbilical cord (lower panel).",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_28_455=[""].join("\n");
var outline_f0_28_455=null;
var title_f0_28_456="Grade III IVH in preterm infant";
var content_f0_28_456=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F87340&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F87340&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 618px\">",
"   <div class=\"ttl\">",
"    Ultasound images of Grade III intraventricular hemorrhage in a preterm infant",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 598px; height: 448px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Coronal (A), axial (B), and sagittal (C, D) images from a transcranial ultrasound examination demonstrate left-sided intraventricular hemorrhage in a preterm infant (gestational age 23 weeks), which occupies more than 50 percent of the total ventricular volume (arrow). The right lateral ventricle is normal (arrowhead, C). The sagittal view (D) shows a level of blood within the left lateral ventricle (dashed arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joseph Farnam, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_28_456=[""].join("\n");
var outline_f0_28_456=null;
var title_f0_28_457="Effects of antiinflammatory and immunosuppressive drugs on gonadal function in men with rheumatic diseases";
var content_f0_28_457=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Effects of antiinflammatory and immunosuppressive drugs on gonadal function in men with rheumatic diseases",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/28/457/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/28/457/contributors\">",
"     Bonnie L Bermas, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/28/457/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/28/457/contributors\">",
"     Peter H Schur, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/28/457/contributors\">",
"     Alvin M Matsumoto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/28/457/contributors\">",
"     Deputy Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/28/457/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/28/457/contributors\">",
"     Kathryn A Martin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/28/457/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H3756984\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of antiinflammatory and immunosuppressive drugs have advanced the treatment of rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, and other rheumatic disorders; however, information regarding the effects of these agents on reproductive function has been limited. Many of the available data have focused on the effects of antiinflammatory and immunosuppressive drugs on pregnancy. However, male gonadal function, particularly spermatogenesis, may be affected by these drugs as well.",
"   </p>",
"   <p>",
"    The effects of drugs used to treat rheumatic disease on male gonadal function will be reviewed here. The impact of these agents on female fertility, pregnancy, and lactation and the effects of cytotoxic agents on gonadal function in adult men are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/59/38842?source=see_link\">",
"     \"Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/14/25834?source=see_link\">",
"     \"Fertility, pregnancy, and nursing in inflammatory bowel disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13706?source=see_link\">",
"     \"Effects of cytotoxic agents on gonadal function in adult men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3759728\">",
"    <span class=\"h1\">",
"     EFFECTS ON MALE GONADAL FUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drug-induced infertility in men, such as that seen with alkylating agents, results from the toxic or suppressive effects of the medications on the testes. The testes contain two anatomical units: the seminiferous tubules, composed of germ cells and Sertoli cells, and the interstitium, containing Leydig cells that produce testosterone. Spermatogenesis is much more likely to be disrupted than testosterone production, because the actively proliferating germinal epithelium of the testes is more sensitive to damage from cytotoxic drugs than are the Leydig cells. Additional factors that may influence gonadal function in patients receiving these medications include effects of the underlying disease (eg, chronic kidney or pulmonary disease). The magnitude of the effect on sperm production is drug-specific, dose-dependent, and duration-dependent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13706?source=see_link&amp;anchor=H2#H2\">",
"     \"Effects of cytotoxic agents on gonadal function in adult men\", section on 'Mechanism of drug-induced infertility'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When a drug has adverse effects on sperm production and function, there is concern that the exposure could also affect fetal outcome. However, unlike teratogenic agents affecting pregnant women, in the male, they do not seem to directly interfere with normal fetal development. (See",
"    <a class=\"local\" href=\"#H3757945\">",
"     'Teratogenic concerns'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3757966\">",
"    <span class=\"h1\">",
"     HIGH RISK OF PERMANENT AZOOSPERMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The chemotherapeutic agents with the most deleterious effect on male fertility are the alkylating agents, which can induce irreversible or prolonged oligozoospermia or azoospermia, compromising fertility. The risk of alkylating agent-related infertility is dose-, age-, and gender-dependent. These drugs all have cumulative dose ranges above which most patients will be rendered permanently infertile. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13706?source=see_link\">",
"     \"Effects of cytotoxic agents on gonadal function in adult men\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Whenever possible, these drugs should be avoided in patients planning future attempts at pregnancy. Prior to receiving these medications, patients should be informed of the potential for cryopreservation of semen containing viable sperm for subsequent use in assisted reproductive technologies such as in vitro fertilization. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13706?source=see_link&amp;anchor=H34#H34\">",
"     \"Effects of cytotoxic agents on gonadal function in adult men\", section on 'Semen cryopreservation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3758895\">",
"    <span class=\"h2\">",
"     Cyclophosphamide",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     Cyclophosphamide",
"    </a>",
"    (CYC) is a cytotoxic alkylating agent, which can have profound effects on male fertility and which may induce permanent infertility. These effects are dose-related; cumulative cyclophosphamide doses of 6 to 10 grams are likely to result in oligospermia and often in irreversible azoospermia. Repeated exposure may be more harmful than single exposure at the same total dose. Male patients receiving doses in this range should be counseled about cryopreservation of sperm. (See",
"    <a class=\"local\" href=\"#H617236150\">",
"     'Semen cryopreservation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    There are insufficient data to define the risk of teratogenicity in the offspring of men treated with CYC. In view of these data and in the absence of direct information about male-mediated teratogenicity caused by CYC use, we suggest that men should discontinue this medication for at least three months and preferably for one year before attempting conception. The longer interval has been proposed to account for the possibility that non-proliferating stem cells and early germ cells may undergo development over a longer time period than one spermatogenic cycle after initial exposure to cytotoxic agents.",
"   </p>",
"   <p>",
"    Additional information regarding the adverse effects, use, and monitoring of this medication is presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13706?source=see_link&amp;anchor=H9#H9\">",
"     \"Effects of cytotoxic agents on gonadal function in adult men\", section on 'Chemotherapeutic agents associated with infertility'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25098?source=see_link\">",
"     \"General toxicity of cyclophosphamide and chlorambucil in inflammatory diseases\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3758926\">",
"    <span class=\"h2\">",
"     Chlorambucil",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/52/35654?source=see_link\">",
"     Chlorambucil",
"    </a>",
"    is an alkylating agent very similar to CYC in terms of its adverse effects, including a dose-dependent impact on sperm production. Chlorambucil is used less often than CYC in clinical practice. Specific details regarding the toxicity, use, and monitoring of this medication are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25098?source=see_link&amp;anchor=H11#H11\">",
"     \"General toxicity of cyclophosphamide and chlorambucil in inflammatory diseases\", section on 'Male gonadal toxicity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3757959\">",
"    <span class=\"h1\">",
"     REVERSIBLE EFFECTS ON SPERM PRODUCTION AND FUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several medications result in reversible adverse effects on male gonadal function, including oligospermia and abnormalities in sperm function. There is strong evidence of such abnormalities resulting from the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/28/8647?source=see_link\">",
"     sulfasalazine",
"    </a>",
"    , and there is limited evidence for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and other nonsteroidal antiinflammatory drugs (NSAIDs).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3757628\">",
"    <span class=\"h2\">",
"     Sulfasalazine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/28/8647?source=see_link\">",
"     Sulfasalazine",
"    </a>",
"    (SSZ) possesses both antiinflammatory properties mediated by its 5-aminosalicylic acid moiety and antibacterial characteristics associated with its sulfapyridine moiety. SSZ has been used since its development in the 1940s as an agent for the treatment of rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/27/2490?source=see_link\">",
"     \"Sulfasalazine in the treatment of rheumatoid arthritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20344?source=see_link\">",
"     \"Sulfasalazine and 5-aminosalicylates in the treatment of inflammatory bowel disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    While SSZ appears to be safe during pregnancy, it has been associated with reversible azoospermia or oligospermia in men, along with reduced sperm motility and an increased proportion of abnormal forms [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. In view of this fact and in the absence of direct information about male-mediated teratogenicity caused by SSZ use, we advise that men should discontinue SSZ for three months before attempting conception; spermatogenesis recovers over two to three months following drug discontinuation [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Specific details regarding the use and monitoring of this medication are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20344?source=see_link\">",
"     \"Sulfasalazine and 5-aminosalicylates in the treatment of inflammatory bowel disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/27/2490?source=see_link\">",
"     \"Sulfasalazine in the treatment of rheumatoid arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3759827\">",
"    <span class=\"h2\">",
"     NSAIDs and aspirin",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are limited data available regarding the effects of nonsteroidal antiinflammatory drugs (NSAIDs), including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , on male gonadal function [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. In general, we advise men that they may remain on NSAIDs, including aspirin, while attempting a pregnancy. In a study of 1376 men attending an infertility clinic who were using nonprescription NSAIDs for at least six months, a decrease in seminal volume, sperm concentration, quality, and motility were noted [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/4\">",
"     4",
"    </a>",
"    ]. The majority of patients were taking aspirin, and the effects were seen primarily in the group of patients taking an average of at least one aspirin or other NSAID pill daily. The clinical significance of these findings is unclear, and the reversibility of these effects was not described.",
"   </p>",
"   <p>",
"    Infertile men taking",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    (ASA) or NSAIDs who are planning to pursue fertility should obtain a semen analysis. The patient may remain on his medication if the analysis is normal, but we advise them to stop the medication if there are abnormalities.",
"   </p>",
"   <p>",
"    Specific details regarding the use and monitoring of these medications are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/36/5703?source=see_link\">",
"     \"NSAIDs: Therapeutic use and variability of response in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17177?source=see_link\">",
"     \"Nonselective NSAIDs: Overview of adverse effects\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/48/13066?source=see_link\">",
"     \"Overview of selective COX-2 inhibitors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/47/2807?source=see_link\">",
"     \"Aspirin: Mechanism of action, major toxicities, and use in rheumatic diseases\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H610166902\">",
"    <span class=\"h1\">",
"     LOW SERUM TESTOSTERONE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term glucocorticoid therapy in men is associated with a decrease in serum testosterone levels, as well as with loss of bone and muscle mass. This is thought to be due to effects of glucocorticoids on both the testes and the pituitary [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. In one study, men with chronic pulmonary disease who received high-dose glucocorticoid therapy for at least one month had a mean serum testosterone concentration of 211",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    (7.3",
"    <span class=\"nowrap\">",
"     nmol/L),",
"    </span>",
"    compared with 449",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    (15.6",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    in men matched for age and disease. Addition of exogenous testosterone therapy helps to minimize these adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/8,10,11\">",
"     8,10,11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link\">",
"     \"Major side effects of systemic glucocorticoids\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/36/17994?source=see_link&amp;anchor=H15#H15\">",
"     \"Prevention and treatment of glucocorticoid-induced osteoporosis\", section on 'Hormone replacement'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31657?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment of osteoporosis in men\", section on 'Testosterone therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3757945\">",
"    <span class=\"h1\">",
"     TERATOGENIC CONCERNS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exposure to certain drugs may alter sperm production and function, suggesting that the drug exposure could affect fetal outcome. However, unlike teratogenic agents affecting pregnant women, in the male, they do not seem to directly interfere with normal fetal development. That said, for a number of drugs, we exercise caution and stop for three months prior to pregnancy to allow for recovery and production of new sperm that have not been exposed to the drug. Three months are necessary because sperm formation takes approximately 70 days from the spermatocyte stage, and the transport of sperm through the epididymis to the ejaculatory ducts requires about 14 days. Some experts advocate waiting one year after exposure to immunomodulatory or immunosuppressive agents for a greater measure of safety. However, the decision to discontinue therapy for a full year prior to attempting conception must be weighed against the absence of data confirming a teratogenic effect of these drugs, as well as against the risks of withdrawing therapy on the patient&rsquo;s underlying chronic disease.",
"   </p>",
"   <p>",
"    Drugs with such teratogenic concerns, which we suggest stopping for at least three months prior to pregnancy, include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       Methotrexate",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"       Mycophenolate",
"      </a>",
"      mofetil",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19015?source=see_link\">",
"       Leflunomide",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3760730\">",
"    <span class=\"h2\">",
"     Methotrexate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Case reports of reversible oligospermia and azoospermia have been described with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    (MTX), a folate antagonist [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. However, in a study of 26 men (age 33 to 52 years) receiving MTX (25",
"    <span class=\"nowrap\">",
"     mg/week),",
"    </span>",
"    no unfavorable effects on fertility were seen, as judged by semen analysis, testicular histology, and spermatogenic activity [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/14\">",
"     14",
"    </a>",
"    ]. Male-mediated teratogenicity with MTX has not been reported. However, given the theoretical risk of teratogenesis and its possible effect on spermatogenesis, we advise men to discontinue MTX for at least three months before attempting conception.",
"   </p>",
"   <p>",
"    Specific details regarding the use and monitoring of this medication are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11223?source=see_link\">",
"     \"Major side effects of low-dose methotrexate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/24/32134?source=see_link\">",
"     \"Hepatotoxicity associated with chronic oral methotrexate for nonmalignant disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/26/32169?source=see_link\">",
"     \"Use of methotrexate in the treatment of rheumatoid arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3759071\">",
"    <span class=\"h2\">",
"     Mycophenolate mofetil",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"     Mycophenolate",
"    </a>",
"    mofetil (MMF), an inhibitor of purine biosynthesis, does not appear to have an adverse effect on spermatogenesis or on fertility. However, MMF may have teratogenic effects, as six cases of congenital anomalies were reported from 45 pregnancies in which there was paternal exposure to MMF [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/15\">",
"     15",
"    </a>",
"    ]. Given these findings, we advise men treated with MMF to discontinue the medication for at least three months before attempting conception.",
"   </p>",
"   <p>",
"    Specific details regarding the use and monitoring of this medication are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/50/2855?source=see_link\">",
"     \"Mycophenolate mofetil: Pharmacology and adverse effects when used in the treatment of rheumatic diseases\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3759160\">",
"    <span class=\"h2\">",
"     Leflunomide",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no evidence that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19015?source=see_link\">",
"     leflunomide",
"    </a>",
"    (LEF) increases the risk of male-mediated fetal toxicity, but we are unaware of studies that have directly examined its safety with respect to male gonadal function. LEF is an antimetabolite that inhibits dihydroorotate dehydrogenase, the enzyme which catalyzes the rate-limiting step in pyrimidine biosynthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/16-21\">",
"     16-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the half-life of LEF is approximately 15 days, its major metabolite (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/45/8918?source=see_link\">",
"     teriflunomide",
"    </a>",
"    ) undergoes extensive enterohepatic circulation and remains detectable in serum for up to two years. Thus, discontinuation of LEF immediately or even several months before conception is insufficient alone for drug elimination. Elimination of the drug and its metabolites can be accelerated by administering",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"     cholestyramine",
"    </a>",
"    (8 grams orally three times daily for 11 days) and can be confirmed by measurement of drug levels less than 0.02",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    on two tests performed two weeks apart. Additional cholestyramine treatment is indicated if plasma levels remain greater than 0.02",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/15\">",
"     15",
"    </a>",
"    ]. (See",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19015?source=see_link\">",
"     \"Leflunomide: Drug information\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    We advise that men taking LEF",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    their female partners should use an effective method of contraception. The manufacturer suggests discontinuing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19015?source=see_link\">",
"     leflunomide",
"    </a>",
"    two years prior to planning pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/17\">",
"     17",
"    </a>",
"    ]. An alternative approach includes",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/33/36374?source=see_link\">",
"     cholestyramine",
"    </a>",
"    administration to accelerate LEF elimination, documentation of undetectable LEF levels, and a subsequent waiting period of at least three months before attempting pregnancy.",
"   </p>",
"   <p>",
"    Specific details regarding the use and monitoring of this medication are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/59/10169?source=see_link\">",
"     \"Leflunomide in the treatment of rheumatoid arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3761710\">",
"    <span class=\"h1\">",
"     NO KNOWN ADVERSE EFFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several medications used in the treatment of rheumatic disease that do not have any known adverse effects on male fertility; the level of evidence supporting their safety varies but is generally limited.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17504417\">",
"    <span class=\"h2\">",
"     Long-used drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Commonly used medications whose reproductive impact has not been studied include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"     hydroxychloroquine",
"    </a>",
"    and intravenous immunoglobulin. Male infertility has not been reported with these agents despite their multiple decades of availability and use. Specific details regarding the general use and monitoring of these medications are presented elsewhere. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"       Hydroxychloroquine",
"      </a>",
"      (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/9/43161?source=see_link\">",
"       \"Antimalarial drugs in the treatment of rheumatic disease\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Intravenous immunoglobulin (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/11/28857?source=see_link\">",
"       \"General principles in the use of immune globulin\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17504436\">",
"    <span class=\"h2\">",
"     Limited studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several drugs that have been the subject of limited study, without evidence of adverse effects upon male fertility, include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"       Azathioprine",
"      </a>",
"      and 6-MP &mdash; Limited studies suggest that azathioprine may be relatively safe with regard to effects on male fertility. These drugs have been widely used in organ transplantation and for inflammatory bowel disease, in addition to their uses in patients with rheumatic disease. Azathioprine (AZA) is metabolized to 6-",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/43/37559?source=see_link\">",
"       mercaptopurine",
"      </a>",
"      (6-MP) in vivo. Thus, these two medications should theoretically have the same effects. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/14/25834?source=see_link&amp;anchor=H521045305#H521045305\">",
"       \"Fertility, pregnancy, and nursing in inflammatory bowel disease\", section on 'Azathioprine and mercaptopurine'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Monotherapy with AZA does not appear to reduce male fertility. In a study of 18 men treated with AZA (1.5 to 2",
"      <span class=\"nowrap\">",
"       mg/kg/day)",
"      </span>",
"      for at least three months for inflammatory bowel disease, sperm counts, motility, and morphology were normal before treatment and were unchanged after 11 to 49 months of treatment [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/22\">",
"       22",
"      </a>",
"      ]. Specific details regarding the use and monitoring of these medications are presented elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/63/10232?source=see_link\">",
"       \"Pharmacology and side effects of azathioprine when used in rheumatic diseases\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/31/7673?source=see_link\">",
"       \"Immunomodulator therapy in Crohn's disease\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/5/21592?source=see_link\">",
"       \"Azathioprine and 6-mercaptopurine in inflammatory bowel disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       Cyclosporine",
"      </a>",
"      &mdash; Cyclosporine A (CSA), a calcineurin inhibitor, does not appear to reduce male fertility or to have a demonstrable effect on sperm density, motility, morphology, volume, or count [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/23\">",
"       23",
"      </a>",
"      ]. Specific details regarding the use and monitoring of this medication and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      , another calcineurin inhibitor, are presented elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28090?source=see_link\">",
"       \"Pharmacology and side effects of cyclosporine and tacrolimus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41945?source=see_link\">",
"       \"Cyclosporine and tacrolimus nephrotoxicity\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      TNF inhibitors &mdash; Some [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/24-26\">",
"       24-26",
"      </a>",
"      ] but not all [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/27,28\">",
"       27,28",
"      </a>",
"      ] studies suggest that tumor necrosis factor (TNF) inhibitors do not impair sperm production or function. Studies have included patients receiving",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/24/39303?source=see_link\">",
"       adalimumab",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/31/28151?source=see_link\">",
"       etanercept",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/6/28776?source=see_link\">",
"       infliximab",
"      </a>",
"      ; there are no data for",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/6/39014?source=see_link\">",
"       certolizumab pegol",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/24/35206?source=see_link\">",
"       golimumab",
"      </a>",
"      .",
"      <br/>",
"      <br/>",
"      Although data are limited, TNF inhibitors appear to be safe for men pursuing fertility. In one study of semen samples from a cohort of 26 patients with spondyloarthropathies (SpA), abnormalities in sperm, including poor motility and vitality, were more pronounced in patients with active SpA who were not receiving TNF inhibitors than in TNF inhibitor-treated patients and in healthy men [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/457/abstract/24\">",
"       24",
"      </a>",
"      ]. Sperm concentration and morphology did not differ between groups.",
"      <br/>",
"      <br/>",
"      Specific details regarding the use and monitoring of these medications are presented elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/19/3384?source=see_link&amp;anchor=H13#H13\">",
"       \"Overview of biologic agents in the rheumatic diseases\", section on 'TNF inhibition'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/55/40825?source=see_link\">",
"       \"Tumor necrosis factor-alpha inhibitors: An overview of adverse effects\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17504400\">",
"    <span class=\"h2\">",
"     Lack of evidence",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is insufficient evidence related to the effects of the following biologic agents on male gonadal function, but targeted biologic agents such as antibodies are not known to have adverse effects on fertility. Specific details regarding the use and monitoring of each of these are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13706?source=see_link&amp;anchor=H15#H15\">",
"     \"Effects of cytotoxic agents on gonadal function in adult men\", section on 'Other agents'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The following drugs fall within this group:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       Rituximab",
"      </a>",
"      &mdash; Rituximab is a chimeric monoclonal antibody that leads to peripheral B cell depletion by targeting the CD20 antigen present on B cell precursors. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21130?source=see_link\">",
"       \"Rituximab and other B cell targeted therapies for rheumatoid arthritis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/14/18662?source=see_link\">",
"       Abatacept",
"      </a>",
"      &mdash; Abatacept (CTLA4-Ig) is an inhibitor of T-cell costimulation, which interferes with T-cell activation by binding to accessory molecules (CD80 and CD86) and by blocking interaction with CD28 (CTLA4). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/0/9223?source=see_link&amp;anchor=H3#H3\">",
"       \"T cell targeted therapies for rheumatoid arthritis\", section on 'Costimulatory molecule inhibition'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/19/44342?source=see_link\">",
"       Tocilizumab",
"      </a>",
"      &mdash; Tocilizumab is an interleukin (IL)-6 receptor inhibitor. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/12/35016?source=see_link&amp;anchor=H5#H5\">",
"       \"Randomized clinical trials in rheumatoid arthritis of biologic agents that inhibit IL-1, IL-6, and RANKL\", section on 'Tocilizumab'",
"      </a>",
"      .).",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/18/294?source=see_link\">",
"       Anakinra",
"      </a>",
"      &mdash; Anakinra is a recombinant human interleukin-1 receptor antagonist. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?3/19/3384?source=see_link&amp;anchor=H19#H19\">",
"       \"Overview of biologic agents in the rheumatic diseases\", section on 'IL-1 inhibition'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3759736\">",
"    <span class=\"h1\">",
"     PRESERVATION OF FERTILITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of strategies have been explored to preserve fertility in men receiving cytotoxic and immunosuppressive medications, including semen cryopreservation and the use of gonadotropin releasing hormone (GnRH) agonists to suppress the pituitary-gonadal axis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H617236150\">",
"    <span class=\"h2\">",
"     Semen cryopreservation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important strategy for preserving fertility is to obtain a semen sample for cryopreservation prior to initiating therapy. This option should be discussed with all patients, including those with low sperm counts. With the advent of in vitro fertilization with intracytoplasmic sperm injection (ICSI), viable pregnancies occur with sperm concentrations that are much lower than normal. Even men with azoospermia should be evaluated to see if there are spermatozoa that could be extracted directly from the testis for ICSI. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13706?source=see_link&amp;anchor=H34#H34\">",
"     \"Effects of cytotoxic agents on gonadal function in adult men\", section on 'Semen cryopreservation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15546?source=see_link\">",
"     \"Intracytoplasmic sperm injection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H617236179\">",
"    <span class=\"h2\">",
"     Hormonal suppression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies using GnRH agonists to reversibly suppress the hypothalamic-pituitary-testicular axis have demonstrated no definitive benefit either in preserving spermatogenesis or in accelerating its recovery. We suggest not using this approach. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13706?source=see_link&amp;anchor=H35#H35\">",
"     \"Effects of cytotoxic agents on gonadal function in adult men\", section on 'Hormonal manipulation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/42/40610?source=see_link\">",
"       \"Patient information: Infertility in men (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?32/5/32851?source=see_link\">",
"       \"Patient information: Treatment of male infertility (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3759533\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is a relative paucity of data regarding the effects on male gonadal function of most antiinflammatory and immunosuppressive drugs used in the treatment of rheumatic diseases. Several mechanisms contribute to drug-induced infertility, particularly medication effects on the germinal epithelium of the testes. There are also concerns that some of these drugs could be teratogenic and could affect fetal outcome. We advise men to discontinue many of these drugs for at least three months prior to pursuing pregnancy, to allow for recovery of spermatogenesis and to avoid any potential teratogenicity. (See",
"      <a class=\"local\" href=\"#H3759728\">",
"       'Effects on male gonadal function'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3757945\">",
"       'Teratogenic concerns'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/52/35654?source=see_link\">",
"       chlorambucil",
"      </a>",
"      be discontinued for one year, if possible, and for a minimum of three months before attempting pregnancy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The alkylating agents cyclophosphamide and chlorambucil are associated with a high risk of irreversible azoospermia and should, therefore, be used with caution in patients anticipating future attempts at pregnancy; the risk of teratogenicity in men is undefined. Patients considering use of these agents should be advised regarding strategies for preservation of fertility (most importantly, semen cryopreservation). (See",
"      <a class=\"local\" href=\"#H3757966\">",
"       'High risk of permanent azoospermia'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H617236150\">",
"       'Semen cryopreservation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/28/8647?source=see_link\">",
"       Sulfasalazine",
"      </a>",
"      can reversibly induce oligospermia or azoospermia, as well as abnormal sperm function. We suggest that sulfasalazine be discontinued three months prior to attempting pregnancy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Very limited data suggest that regular use of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      and nonsteroidal antiinflammatory drugs may have, at most, modest effects on sperm number and function with chronic use. (See",
"      <a class=\"local\" href=\"#H3757959\">",
"       'Reversible effects on sperm production and function'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3757628\">",
"       'Sulfasalazine'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3759827\">",
"       'NSAIDs and aspirin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Several drugs, including",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"       mycophenolate",
"      </a>",
"      mofetil, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19015?source=see_link\">",
"       leflunomide",
"      </a>",
"      , have not been associated with adverse effects on male gonadal function, but, because of their mechanisms of action or suspected effects as teratogens, we exercise particular caution in men using these medications. We suggest that they be discontinued, if possible, for at least three months prior to attempting pregnancy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3757945\">",
"       'Teratogenic concerns'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/26/2471?source=see_link\">",
"       Hydroxychloroquine",
"      </a>",
"      and intravenous immunoglobulin are widely used and are not known to have adverse effects on male gonadal function.",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"       Azathioprine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      have been the subject of limited study, without evidence of adverse effects upon male fertility. (See",
"      <a class=\"local\" href=\"#H17504436\">",
"       'Limited studies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17504417\">",
"       'Long-used drugs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The impact of most biologic agents on male gonadal function is unknown, but targeted biologic agents such as antibodies are not known to have adverse effects on fertility. These medications include TNF inhibitors,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/18/294?source=see_link\">",
"       anakinra",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"       rituximab",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/14/18662?source=see_link\">",
"       abatacept",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/19/44342?source=see_link\">",
"       tocilizumab",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H17504436\">",
"       'Limited studies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17504400\">",
"       'Lack of evidence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most important strategy for preserving fertility is to obtain a semen sample for cryopreservation prior to initiating therapy. We suggest not using gonadotropin releasing hormone (GnRH) agonists in efforts to preserve fertility (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). This approach has not been shown either to preserve spermatogenesis or to accelerate its recovery. (See",
"      <a class=\"local\" href=\"#H3759736\">",
"       'Preservation of fertility'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13706?source=see_link&amp;anchor=H35#H35\">",
"       \"Effects of cytotoxic agents on gonadal function in adult men\", section on 'Hormonal manipulation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/1\">",
"      Birnie GG, McLeod TI, Watkinson G. Incidence of sulphasalazine-induced male infertility. Gut 1981; 22:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/2\">",
"      Toovey S, Hudson E, Hendry WF, Levi AJ. Sulphasalazine and male infertility: reversibility and possible mechanism. Gut 1981; 22:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/3\">",
"      O'Mor&aacute;in C, Smethurst P, Dor&eacute; CJ, Levi AJ. Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 1984; 25:1078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/4\">",
"      Martini AC, Molina RI, Tissera AD, et al. Analysis of semen from patients chronically treated with low or moderate doses of aspirin-like drugs. Fertil Steril 2003; 80:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/5\">",
"      Porat-Soldin O, Soldin SJ. Preliminary studies on the in vitro and in vivo effect of salicylate on sperm motility. Ther Drug Monit 1992; 14:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/6\">",
"      Ingram MJ, Zeller E, Moss GP, Hall CE. A potential anti-implantation and spermicidal strategy: putative derivatives of nonoxynol-9 and anti-inflammatory agents and their spermicidal activity. Eur J Contracept Reprod Health Care 2006; 11:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/7\">",
"      MacAdams MR, White RH, Chipps BE. Reduction of serum testosterone levels during chronic glucocorticoid therapy. Ann Intern Med 1986; 104:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/8\">",
"      Odell WD. Testosterone treatment of men treated with glucocorticoids. Arch Intern Med 1996; 156:1133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/9\">",
"      Kamischke A, Kemper DE, Castel MA, et al. Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 1998; 11:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/10\">",
"      Crawford BA, Liu PY, Kean MT, et al. Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment. J Clin Endocrinol Metab 2003; 88:3167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/11\">",
"      Reid IR, Wattie DJ, Evans MC, Stapleton JP. Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 1996; 156:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/12\">",
"      Sussman A, Leonard JM. Psoriasis, methotrexate, and oligospermia. Arch Dermatol 1980; 116:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/13\">",
"      Hinkes E, Plotkin D. Reversible drug-induced sterility in a patient with acute leukemia. JAMA 1973; 223:1490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/14\">",
"      El-Beheiry A, El-Mansy E, Kamel N, Salama N. Methotrexate and fertility in men. Arch Androl 1979; 3:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/15\">",
"      &Oslash;stensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006; 8:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/16\">",
"      Chakravarty EF, Sanchez-Yamamoto D, Bush TM. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J Rheumatol 2003; 30:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/17\">",
"      Brent RL. Teratogen update: reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child. Teratology 2001; 63:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/18\">",
"      De Santis M, Straface G, Cavaliere A, et al. Paternal and maternal exposure to leflunomide: pregnancy and neonatal outcome. Ann Rheum Dis 2005; 64:1096.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/19\">",
"      Heine K, Poets CF. A pair of twins born after maternal exposure to leflunomide. J Perinatol 2008; 28:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/20\">",
"      Neville CE, McNally J. Maternal exposure to leflunomide associated with blindness and cerebral palsy. Rheumatology (Oxford) 2007; 46:1506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/21\">",
"      Chambers CD, Johnson DL, Robinson LK, et al. Birth outcomes in women who have taken leflunomide during pregnancy. Arthritis Rheum 2010; 62:1494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/22\">",
"      Dejaco C, Mittermaier C, Reinisch W, et al. Azathioprine treatment and male fertility in inflammatory bowel disease. Gastroenterology 2001; 121:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/23\">",
"      Haberman J, Karwa G, Greenstein SM, et al. Male fertility in cyclosporine-treated renal transplant patients. J Urol 1991; 145:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/24\">",
"      Villiger PM, Caliezi G, Cottin V, et al. Effects of TNF antagonists on sperm characteristics in patients with spondyloarthritis. Ann Rheum Dis 2010; 69:1842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/25\">",
"      Paschou S, Voulgari PV, Vrabie IG, et al. Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab. J Rheumatol 2009; 36:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/26\">",
"      Said TM, Agarwal A, Falcone T, et al. Infliximab may reverse the toxic effects induced by tumor necrosis factor alpha in human spermatozoa: an in vitro model. Fertil Steril 2005; 83:1665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/27\">",
"      Montagna GL, Malesci D, Buono R, Valentini G. Asthenoazoospermia in patients receiving anti-tumour necrosis factor {alpha} agents. Ann Rheum Dis 2005; 64:1667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/457/abstract/28\">",
"      Mahadevan U, Terdiman JP, Aron J, et al. Infliximab and semen quality in men with inflammatory bowel disease. Inflamm Bowel Dis 2005; 11:395.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15904 Version 1.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-27.109.116.13-83254367CA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_28_457=[""].join("\n");
var outline_f0_28_457=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3759533\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3756984\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3759728\">",
"      EFFECTS ON MALE GONADAL FUNCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3757966\">",
"      HIGH RISK OF PERMANENT AZOOSPERMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3758895\">",
"      Cyclophosphamide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3758926\">",
"      Chlorambucil",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3757959\">",
"      REVERSIBLE EFFECTS ON SPERM PRODUCTION AND FUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3757628\">",
"      Sulfasalazine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3759827\">",
"      NSAIDs and aspirin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H610166902\">",
"      LOW SERUM TESTOSTERONE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3757945\">",
"      TERATOGENIC CONCERNS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3760730\">",
"      Methotrexate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3759071\">",
"      Mycophenolate mofetil",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3759160\">",
"      Leflunomide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3761710\">",
"      NO KNOWN ADVERSE EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17504417\">",
"      Long-used drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17504436\">",
"      Limited studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17504400\">",
"      Lack of evidence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3759736\">",
"      PRESERVATION OF FERTILITY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H617236150\">",
"      Semen cryopreservation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H617236179\">",
"      Hormonal suppression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3759533\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/9/43161?source=related_link\">",
"      Antimalarial drugs in the treatment of rheumatic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/47/2807?source=related_link\">",
"      Aspirin: Mechanism of action, major toxicities, and use in rheumatic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/5/21592?source=related_link\">",
"      Azathioprine and 6-mercaptopurine in inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/61/41945?source=related_link\">",
"      Cyclosporine and tacrolimus nephrotoxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/24/13706?source=related_link\">",
"      Effects of cytotoxic agents on gonadal function in adult men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/14/25834?source=related_link\">",
"      Fertility, pregnancy, and nursing in inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/11/28857?source=related_link\">",
"      General principles in the use of immune globulin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25098?source=related_link\">",
"      General toxicity of cyclophosphamide and chlorambucil in inflammatory diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/24/32134?source=related_link\">",
"      Hepatotoxicity associated with chronic oral methotrexate for nonmalignant disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/31/7673?source=related_link\">",
"      Immunomodulator therapy in Crohn's disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/11/15546?source=related_link\">",
"      Intracytoplasmic sperm injection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/59/10169?source=related_link\">",
"      Leflunomide in the treatment of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19015?source=related_link\">",
"      Leflunomide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/61/11223?source=related_link\">",
"      Major side effects of low-dose methotrexate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/50/2855?source=related_link\">",
"      Mycophenolate mofetil: Pharmacology and adverse effects when used in the treatment of rheumatic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/36/5703?source=related_link\">",
"      NSAIDs: Therapeutic use and variability of response in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/49/17177?source=related_link\">",
"      Nonselective NSAIDs: Overview of adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/19/3384?source=related_link\">",
"      Overview of biologic agents in the rheumatic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/48/13066?source=related_link\">",
"      Overview of selective COX-2 inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/42/40610?source=related_link\">",
"      Patient information: Infertility in men (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?32/5/32851?source=related_link\">",
"      Patient information: Treatment of male infertility (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/63/10232?source=related_link\">",
"      Pharmacology and side effects of azathioprine when used in rheumatic diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28090?source=related_link\">",
"      Pharmacology and side effects of cyclosporine and tacrolimus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/36/17994?source=related_link\">",
"      Prevention and treatment of glucocorticoid-induced osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/12/35016?source=related_link\">",
"      Randomized clinical trials in rheumatoid arthritis of biologic agents that inhibit IL-1, IL-6, and RANKL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/40/21130?source=related_link\">",
"      Rituximab and other B cell targeted therapies for rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/55/20344?source=related_link\">",
"      Sulfasalazine and 5-aminosalicylates in the treatment of inflammatory bowel disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/27/2490?source=related_link\">",
"      Sulfasalazine in the treatment of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/0/9223?source=related_link\">",
"      T cell targeted therapies for rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31657?source=related_link\">",
"      Treatment of osteoporosis in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/55/40825?source=related_link\">",
"      Tumor necrosis factor-alpha inhibitors: An overview of adverse effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/59/38842?source=related_link\">",
"      Use of antiinflammatory and immunosuppressive drugs in rheumatic diseases during pregnancy and lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/26/32169?source=related_link\">",
"      Use of methotrexate in the treatment of rheumatoid arthritis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_28_458="Nutritional composition of human milk and preterm formula for the premature infant";
var content_f0_28_458=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Nutritional composition of human milk and preterm formula for the premature infant",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/28/458/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/28/458/contributors\">",
"     Richard J Schanler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/28/458/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/28/458/contributors\">",
"     Steven A Abrams, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?0/28/458/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?0/28/458/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?0/28/458/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enteral nutrition can be provided to premature infants with either human milk or commercial premature formulas. The American Academy of Pediatrics (AAP) recommends human milk as the preferred feeding for all infants, although supplementation utilizing human milk fortifiers is required to meet the nutritional needs of premature newborns [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/1\">",
"     1",
"    </a>",
"    ]. The feeding of human milk for premature infants, including the use of human milk fortifiers, is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23655?source=see_link\">",
"     \"Human milk feeding and fortification of human milk for premature infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although human milk is the preferred feeding, premature formula is an option if there is an inadequate supply of mother's milk or if the mother is unable to breastfeed. Premature formula meets nutrient needs of the growing premature infant but does not replicate the many bioactive factors in human milk.",
"   </p>",
"   <p>",
"    This topic review will compare the various components of human milk and premature formula with respect to their ability to meet the nutritional requirements of the premature infant.",
"   </p>",
"   <p>",
"    The approach to enteral feedings in the premature infant, including determination of nutrient and energy requirements, methods of feeding, and assessment of feeding intolerance, and the composition of human milk for all term infants are discussed elsewhere (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/8/19593?source=see_link\">",
"     \"Approach to enteral nutrition in the premature infant\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/36/6727?source=see_link\">",
"     \"Nutritional composition of human milk for full-term infants\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature infants have greater nutritional needs to achieve optimal growth in the neonatal period than at any other time of their life. There are several reasons for this:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infants born at the beginning of the third trimester of pregnancy often are growth-restricted because of decreased intrauterine nutrient deposition [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/2\">",
"       2",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Medical conditions, including hypotension, hypoxia, acidosis, infection, and surgery, increase metabolic energy requirements and, thus, nutrient needs.",
"     </li>",
"     <li>",
"      Additional impediments to growth are physiologic immaturity of the gastrointestinal tract, including decreased gastrointestinal motility and reduced intestinal enzyme activity, and therapies such as corticosteroids.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Fortification of human milk is required to meet the increased nutritional needs of the preterm infant. If human milk is not available, preterm formula, which is enriched in protein, energy content, minerals, and micronutrients, should be provided to the preterm infant. This nutritional support helps to correct growth restriction at birth and to achieve an appropriate rate of weight gain, which is almost twice that of a term infant [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. In addition, a high-nutrient versus low-nutrient content human milk appears to be associated with improved cognitive ability in adolescents who were born &le;30 weeks gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Parenteral nutrition is necessary for infants whose immaturity or medical condition precludes enteral feeding. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/50/27434?source=see_link\">",
"     \"Parenteral nutrition in premature infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PROTEIN",
"    </span>",
"    &nbsp;&mdash;&nbsp;In milk, there are two fractions of protein defined by their solubility in acid: whey and casein. The predominance of whey and the amino acid composition of human milk and premature formula compared to bovine milk is beneficial for premature infants even when compared with formula [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Whey predominance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both human milk and premature formula contain an increased proportion of whey to casein. Human milk is 70 percent whey and 30 percent casein, and premature formula is 60 percent whey and 40 percent casein. In contrast, bovine milk contains predominantly casein (82 percent). The high proportion of whey in human milk, which is also found in premature formula, is beneficial for premature infants for several reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Whey-dominant milk promotes more rapid gastric emptying than does casein-dominant milk [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The whey fraction consists of soluble proteins that are more easily digested [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/8\">",
"       8",
"      </a>",
"      ], so hydrolyzed protein (contained in elemental formulas) is not necessary for premature infants. The major human whey protein is alpha-lactalbumin, a nutritional protein. The major bovine whey protein is beta-lactoglobulin, which may contribute to protein allergy and colic [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/9,10\">",
"       9,10",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14808?source=see_link\">",
"       \"Clinical manifestations of food allergy: An overview\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/27/10680?source=see_link&amp;anchor=H8#H8\">",
"       \"Clinical features and etiology of colic\", section on 'Cow's milk protein'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other specific human whey proteins are lactoferrin, lysozyme, and secretory IgA. These proteins are resistant to hydrolysis, line the gastrointestinal tract, and may play a role in host defense [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]. Bovine milk contains only trace amounts of these proteins. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/36/6727?source=see_link\">",
"       \"Nutritional composition of human milk for full-term infants\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23655?source=see_link&amp;anchor=H3#H3\">",
"       \"Human milk feeding and fortification of human milk for premature infants\", section on 'Improved host defense'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Amino acid content",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasma concentrations of amino acids are more conducive to brain development in premature infants fed human milk or whey-dominant formula than casein-dominant formula. In one study, human milk providing 1.6",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    protein per day was compared to whey or casein-dominant formulas providing 2.25 or 4.50",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    protein per day [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/13\">",
"     13",
"    </a>",
"    ]. Infants fed human milk had the lowest concentrations of methionine, phenylalanine, and tyrosine [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]; high levels of these amino acids may interfere with brain development.",
"   </p>",
"   <p>",
"    In addition, human milk and premature formula contain cysteine and taurine, two amino acids that are deficient in premature infants [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Cysteine is needed to synthesize the antioxidant glutathione and taurine is needed for bile conjugation and brain development.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Requirements",
"    </span>",
"    &nbsp;&mdash;&nbsp;A healthy premature infant requires a protein intake of approximately 3.5 to 4.0",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    per day with an energy requirement of 120",
"    <span class=\"nowrap\">",
"     kcal/kg",
"    </span>",
"    per day (",
"    <a class=\"graphic graphic_table graphicRef60637 \" href=\"UTD.htm?37/11/38077\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef59766 \" href=\"UTD.htm?26/32/27147\">",
"     table 2",
"    </a>",
"    ). Support for this recommendation includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A meta-analysis of low birth weight infants (birth weight &lt;2500 gm) compared protein intake of &ge;3",
"      <span class=\"nowrap\">",
"       g/kg",
"      </span>",
"      per day (but &lt;4",
"      <span class=\"nowrap\">",
"       g/kg",
"      </span>",
"      per day) to a lower intake &lt;3",
"      <span class=\"nowrap\">",
"       g/kg",
"      </span>",
"      per day in five randomized studies [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/18\">",
"       18",
"      </a>",
"      ]. Infants with a higher protein intake demonstrated better weight gains and had a greater nitrogen accretion rate, suggesting that some or all of the increase in weight gain was due to a gain in lean body mass. There was no difference in the plasma phenylalanine level between the two groups.",
"     </li>",
"     <li>",
"      Two additional studies published after the meta-analysis provided support for protein intakes greater than 3.5",
"      <span class=\"nowrap\">",
"       g/100",
"      </span>",
"      kcal.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In the first study, 18 very low birth weight (VLBW) infants (birth weight &lt;1500 g) had increased protein accretion and better weight gain during the week when they received a protein intake of 3.6",
"      <span class=\"nowrap\">",
"       g/100",
"      </span>",
"      kcal compared with a lower intake of 3",
"      <span class=\"nowrap\">",
"       g/100",
"      </span>",
"      kcal for one week [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a small trial of 23 preterm infants (birth weight &lt;1250 g), patients who were randomly selected to protein and energy supplementation (protein intake of 4.1",
"      <span class=\"nowrap\">",
"       g/100",
"      </span>",
"      kcal) had in-hospital improved growth including weight gain compared with those who only received energy supplementation [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These results demonstrate that higher protein intake is tolerated by premature infants and is associated with improved growth compared to lower protein intake.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Supplementation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neither human milk nor preterm formula meet the protein requirements for premature infants. Although the protein content of milk from mothers who deliver premature infants (preterm milk) may be as high as 3.2",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    initially, protein content declines over four weeks to a level of 1.8",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/21-25\">",
"     21-25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fortification of milk to achieve a protein intake of 3 to 4.0",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    per day improves rates of weight gain and indices of protein nutritional status such as blood urea nitrogen, serum albumin, and transthyretin [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/26-31\">",
"     26-31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Human milk fortifiers used to supplement breast milk contain lyophilized protein that can be human or bovine. Both sources have similar effects on nitrogen utilization and growth. However, the protein source may affect plasma amino acid patterns. As an example, plasma concentrations of cystine, taurine, and proline are greater when lyophilized human milk protein is added [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/6,32\">",
"     6,32",
"    </a>",
"    ]. In comparison, mixing liquid commercial term formula with human milk may not provide sufficient protein to meet the needs of the premature infant [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     LIPID",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lipid (fat) comprises nearly 50 percent of the caloric content of milk and is the major energy source [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/34\">",
"     34",
"    </a>",
"    ]. Lipids in human milk may be particularly suitable for the premature infant because of the complex organization of the fat globule, the pattern of fatty acids, and the presence of bile salt-stimulated lipase [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. These factors promote the digestion and absorption of lipid. As an example, in a small study, fecal lipid excretion was lower in premature infants fed a mixture of fresh human milk and formula compared to those fed 100 percent formula (5 versus 12 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Medium chain fatty acids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medium chain fatty acids (MCFA), 6 to 12 carbons in length, account for less than 12 percent of fatty acids in human milk [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/38\">",
"     38",
"    </a>",
"    ]. The lipid content of formulas is modified to approximate lipid absorption in human milk, resulting in differences in the constituent of fatty acids. As an example, premature formulas are modified to increase the MCFA content to 40 percent of lipids. Thus, MCFA supplementation in preterm formula changes the overall distribution of fatty acids when compared to human milk with MCFA contributing 40 versus 12 percent of fatty acid content, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/35,36\">",
"     35,36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This increase in MCFA in preterm formulas is controversial. Although initial studies demonstrated that MCFA were more easily absorbed than saturated fatty acids, subsequent studies have failed to identify a benefit of MCFA compared to polysaturated fatty acids. Substituting MCFA for long chain fatty acids (LCFA) in formula did not improve weight gain or absorption of lipid or minerals [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. In premature infants fed formulas with 46 versus 4 percent MCFA, there were",
"    <strong>",
"     no",
"    </strong>",
"    differences in nitrogen retention, weight gain, or energy digestibility, expenditure and storage [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/40\">",
"     40",
"    </a>",
"    ]. Furthermore, there may be problems associated with the addition of MCFA compared to LCFA, such as incomplete oxidation of MCFA, which may contribute to increased urinary dicarboxylic acid excretion and metabolic inefficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/42-45\">",
"     42-45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Long-chain polyunsaturated fatty acids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-chain polyunsaturated fatty acids (LCPUFA, greater than 12 carbons in length), such as arachidonic and docosahexaenoic acids, are derived from linoleic and linolenic acids. They are components of phospholipids found in brain, retina, and red cell membranes [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/46-50\">",
"     46-50",
"    </a>",
"    ] and are present in human milk but not in bovine milk. In premature infants, supplementation of formula with arachidonic and docosahexaenoic acids results in concentrations of docosahexaenoic acid (DHA) in red blood cells similar to those seen in premature infants fed human milk [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are limited direct data on the long-term effect of LCPUFA supplementation in preterm infants and indirect information from studies in formula-fed term infants. However, data are inconclusive as results vary on whether or not LCPUFA supplementation is beneficial in either group of infants.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A randomized study of 470 preterm infants demonstrated improved visual acuity, motor development, and vocabulary comprehension in patients that received premature infant formula supplemented with LCPUFA compared to those without supplementation [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/51\">",
"       51",
"      </a>",
"      ]. There were no adverse effects seen in the infants who received supplementation.",
"     </li>",
"     <li>",
"      A meta-analysis of studies published through 2002, including the above study, found that supplementation of formula with LCPUFA may increase early visual maturation in premature infants but showed no benefit in developmental outcome or growth [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/52\">",
"       52",
"      </a>",
"      ]. This analysis was hampered by variations in composition and concentration of LCPUFA used in the different studies.",
"     </li>",
"     <li>",
"      A subsequent randomized double-blinded study of 361 preterm infants showed enhanced growth in patients who received LCPUFA compared to control patients [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/53\">",
"       53",
"      </a>",
"      ]. There was also a trend for treated patients to score higher on developmental outcome tests at 18 months adjusted gestational age. These scores were lower than those achieved by breast-fed term infants, and the study lacked a breast-fed preterm infant group for comparison. There was no increase in morbidity or adverse events in the treated groups compared to control infants.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, the following studies have shown no additional benefit in outcome from LCPUFA supplementation:",
"   </p>",
"   <p>",
"    A meta-analysis of studies in term infants reported no beneficial effects on the neurodevelopmental outcome or physical growth of LCPUFA supplemented formula versus nonsupplemented formula [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/54\">",
"     54",
"    </a>",
"    ]. The findings were inconsistent regarding the effect of LCPUFA supplementation on visual acuity with four of the nine studies reporting a beneficial effect, while the remaining did not.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A randomized, double-blinded trial of 657 preterm infants less than 33 weeks gestation found no overall difference in Bayley Mental Developmental Index (MDI) scores at 18 months corrected age between the infants assigned to high DHA enteral feeds (approximately 1 percent of total fatty acids) compared to those who received standard DHA feeds [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/55\">",
"       55",
"      </a>",
"      ]. Higher MDI scores, however, were noted in girls who received high DHA feeds compared to control girls. In this trial, almost all the infants initially received their mother's breast milk, and 40 percent were still exclusively breast fed at the expected date of delivery. DHA delivery was reliant upon lactating mothers' consumption of DHA capsules. Maternal adherence based upon capsule return was 81 percent and the mean breast milk DHA concentration was greater for women assigned the high DHA group. There were no differences in the rates of maternal or infant adverse events between the two groups. In addition, a follow-up report of infants at 26 months corrected age showed no difference between the two groups in language development or behavior [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A meta-analysis published in 2010 that included 870 preterm and term infants found no evidence that LCPUFA supplementation improved Bayley mental or psychomotor index scores [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a randomized, double-blinded trial, there were no differences in cardiovascular or anthropometric measurements at nine years of age between children who received LCPUFA formula supplementation as infants (n = 145) born at term compared with those who received a standard non-LCPUFA supplemented formula (n = 159) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/58\">",
"       58",
"      </a>",
"      ]. Children who received human milk had marginally lower heart rate but had similar blood pressure and growth parameters to the formula-fed groups.",
"     </li>",
"     <li>",
"      In a British follow-up study of a randomized neonatal trial of LCPUFA supplementation in premature infants, cognitive development was similar in children who were who received LCPUFA supplementation compared to controls at 10 years of age [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/59\">",
"       59",
"      </a>",
"      ]. In the subgroup of infants who only received preterm formula, those in the LCPUFA supplemented group had greater cognitive test scores compared with those not supplemented. However, for infants who were breastfed, there were no differences in cognitive scores between LCPUFA supplementation and nonsupplemented infants, and both groups had similar scores to the preterm formula fed subgroup that received LCPUFA supplementation. Thus, there may be a beneficial effect of LCPUFA supplementation in the non-breastfed group of premature infants.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Lipid in human milk",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lipid content of human milk is different in different women. Other parameters that affect lipid content include [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/60-63\">",
"     60-63",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Duration of lactation (rises slightly as lactation continues)",
"     </li>",
"     <li>",
"      Time of day (varies throughout the day)",
"     </li>",
"     <li>",
"      Phase of milk expression (increases from beginning to end during a single milk expression)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These variations result in differences in lipid content from 2.2 to 4.7",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    and contribute to variations in energy content [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/64\">",
"     64",
"    </a>",
"    ]. The quantity of lipid in milk, however, is unrelated to the quantity of fat in the maternal diet.",
"   </p>",
"   <p>",
"    The lipid content of hindmilk (milk at end of expression) may be 1.5 to 3 times more than that of foremilk (milk at beginning of expression) contributing 55 versus 42 percent of calories, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/63\">",
"     63",
"    </a>",
"    ]. If the mother of a hospitalized premature infant produces more milk than her infant needs, the expressed milk can be fractionated and hindmilk used exclusively. This is accomplished by discarding the first five minutes of milk expression (foremilk) and collecting the remainder (hindmilk).",
"   </p>",
"   <p>",
"    In one study, the additional lipid and energy intake from hindmilk improved weight gain in premature infants [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/63\">",
"     63",
"    </a>",
"    ]. However, caution is advised because the lower protein content of hindmilk compared to foremilk (9 versus 12 percent of calories) is less than the 10 to 12 percent of protein calories recommended for premature infants. Addition of commercial human milk fortifiers to hindmilk increases the proportion of protein calories to approximately 12 percent.",
"   </p>",
"   <p>",
"    If excess milk is available, we recommend use of fortified hindmilk for premature infants with weight gain less than 15",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    per day.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Delivery of lipid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lipid separates in standing human milk because human milk is not homogenized [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/38,65\">",
"     38,65",
"    </a>",
"    ]. Separated lipid may adhere to collection containers, feeding tubes, and syringes, thereby decreasing the delivery of lipid to the infant [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/66\">",
"     66",
"    </a>",
"    ]. Lipid delivery is more efficient with bolus compared to continuous tubing feeding. Improved delivery of both can be achieved by using short tubing and a vertical syringe. With this method, lipid delivery was improved from 8 to 48 percent in one report of infants receiving continuous tube feedings [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     CARBOHYDRATE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carbohydrates, comprised primarily of lactose and oligosaccharides, contribute approximately 40 percent of the calories in human milk. Premature infants can absorb more than 90 percent of the lactose in human milk [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. A small amount of unabsorbed lactose normally is present in stool of infants fed human milk, and may contribute to softer stool consistency, more nonpathogenic bacterial fecal flora, and improved absorption of minerals [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/69-71\">",
"     69-71",
"    </a>",
"    ]. Feeding human milk to premature infants stimulates intestinal",
"    <a class=\"drug drug_general\" href=\"UTD.htm?13/62/14306?source=see_link\">",
"     lactase",
"    </a>",
"    activity, which may promote better utilization of lactose when compared to formula or no feeding [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The data are conflicted on whether reduction of the proportion of lactose in premature formulas decreases mineral absorption. In one study, mineral absorption was greater with a formula that contained only lactose compared to sucrose and corn syrup solids (glucose polymers) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/71\">",
"     71",
"    </a>",
"    ]. In another report, formulas containing only lactose or a mixture of lactose and glucose polymers had similar mineral absorption [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/73\">",
"     73",
"    </a>",
"    ]. In contrast to human milk, current premature formulas usually contain equal proportions of lactose and glucose polymers. This combination results in lower osmolality than does lactose alone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     CALCIUM AND PHOSPHORUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following is a brief summary of the issues regarding calcium and phosphorus requirements in the premature infants. A detailed discussion of these issues is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40567?source=see_link&amp;anchor=H5#H5\">",
"     \"Calcium and phosphorus requirements of newborn infants\", section on 'Requirements in preterm infants'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Human milk &mdash; Preterm human milk contains approximately 6.25",
"      <span class=\"nowrap\">",
"       mmol/L",
"      </span>",
"      (250",
"      <span class=\"nowrap\">",
"       mg/L)",
"      </span>",
"      of calcium (Ca) and 4.5",
"      <span class=\"nowrap\">",
"       mmol/L",
"      </span>",
"      (140",
"      <span class=\"nowrap\">",
"       mg/L)",
"      </span>",
"      of phosphorus (P) [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/22\">",
"       22",
"      </a>",
"      ]. The content of Ca and P in human milk is insufficient for premature infants to achieve intrauterine accretion rates or normal bone mineralization (",
"      <a class=\"graphic graphic_table graphicRef65718 \" href=\"UTD.htm?23/24/23947\">",
"       table 3",
"      </a>",
"      ). Human milk should be supplemented with Ca and P because supplementation improves linear growth and bone mineralization. For premature infants, we recommend the addition of Ca (2 to 3",
"      <span class=\"nowrap\">",
"       mmol/kg",
"      </span>",
"      per day",
"      <strong>",
"       or",
"      </strong>",
"      80 to 120",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day) and P (1.5 to 2",
"      <span class=\"nowrap\">",
"       mmol/kg",
"      </span>",
"      per day",
"      <strong>",
"       or",
"      </strong>",
"      45 to 60",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day) to human milk after enteral feeding is established.",
"     </li>",
"     <li>",
"      Preterm formula &mdash; Preterm formula in a volume of 150",
"      <span class=\"nowrap\">",
"       mL/kg",
"      </span>",
"      per day provides daily intakes of approximately 5",
"      <span class=\"nowrap\">",
"       mmol/kg",
"      </span>",
"      (200",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      Ca and 3",
"      <span class=\"nowrap\">",
"       mmol/kg",
"      </span>",
"      (100",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      P, which meet estimates of intrauterine accretion (",
"      <a class=\"graphic graphic_table graphicRef65718 \" href=\"UTD.htm?23/24/23947\">",
"       table 3",
"      </a>",
"      ). However, quantities of Ca and P in formulas for term infants and other specialized (not premature) formulas are not adequate to meet the mineral needs of premature infants.",
"     </li>",
"     <li>",
"      After discharge &mdash; After discharge, sufficient Ca and P must be provided for premature infants to maintain adequate bone mineralization for growth. Growth is closely monitored in VLBW infants who are discharged feeding on human milk exclusively. Possible mineral deficiency is assessed after four to eight weeks by measuring serum phosphorus concentration and alkaline phosphatase activity. If these values are abnormal, a radiograph of the long bones is obtained to assess mineralization. Mineral supplementation is provided if osteopenia is present.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     MAGNESIUM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preterm human milk contains approximately 1.3",
"    <span class=\"nowrap\">",
"     mmol/L",
"    </span>",
"    (30",
"    <span class=\"nowrap\">",
"     mg/L)",
"    </span>",
"    of magnesium (Mg) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/22\">",
"     22",
"    </a>",
"    ]. Mg absorption is greater in unfortified human milk than in formula (73 versus 48 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/74\">",
"     74",
"    </a>",
"    ]. Balance studies show that net Mg retention in premature infants fed human milk meets intrauterine estimates, [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/74,75\">",
"     74,75",
"    </a>",
"    ] and, therefore, supplementation is not needed. Mg accretion is greater than intrauterine estimates in premature infants fed premature formulas, even though absorption is less than with human milk. The effect of this greater Mg intake and retention is unknown.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SODIUM",
"    </span>",
"    &nbsp;&mdash;&nbsp;A sodium (Na) intake of 2 to 3",
"    <span class=\"nowrap\">",
"     mmol/kg",
"    </span>",
"    (2 to 3",
"    <span class=\"nowrap\">",
"     mEq/kg)",
"    </span>",
"    per day allows growth and maintains an appropriate serum Na concentration in premature infants. Because the Na concentration of human milk is low and declines as lactation progresses, premature infants fed unsupplemented human milk may develop hyponatremia [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/76\">",
"     76",
"    </a>",
"    ]. Human milk fortifiers provide adequate sodium supplementation to ensure normal serum sodium levels [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     POTASSIUM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recommended intake of potassium is 2 to 3",
"    <span class=\"nowrap\">",
"     mmol/kg",
"    </span>",
"    (2 to 3 mEq",
"    <span class=\"nowrap\">",
"     /kg)",
"    </span>",
"    per day, the amount provided by both human milk and premature formula.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     IRON",
"    </span>",
"    &nbsp;&mdash;&nbsp;The iron (Fe) concentration declines in human milk as lactation continues, from approximately 0.6",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    at two weeks to 0.3",
"    <span class=\"nowrap\">",
"     mg/L",
"    </span>",
"    after five months [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/78\">",
"     78",
"    </a>",
"    ]. Bioavailability is approximately 50 percent in human milk. Bioavailability is increased by mild anemia and reduced by blood transfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/79,80\">",
"     79,80",
"    </a>",
"    ]. Premature infants fed human milk develop Fe deficiency, which can be prevented by Fe supplementation [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We agree with the American Academy of Pediatrics (AAP) recommendation that iron supplementation of 2 to 4",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day be given to all preterm infants either as a supplement to those fed human milk or as iron-fortified formula [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/82\">",
"     82",
"    </a>",
"    ]. For infants receiving human milk, iron at a dose of at least 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day is started after two weeks of age, whereas infants who are fed formula should be given iron-fortified formula from the onset. Iron is given at a dose of at least 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day through the first year of life. Further supplementation with iron may be needed and is discussed elsewhere in the program. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=see_link\">",
"     \"Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In other countries, higher Fe supplementation is routinely administered. As an example, in Norway, Fe is given as a dose of 18",
"    <span class=\"nowrap\">",
"     mg/day,",
"    </span>",
"    which is not adjusted for weight. Thus, in very low birth weight infants, this regimen can deliver up to 18",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    of Fe. In one study, one week of high dose Fe supplementation (18",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    increased serum iron and transferrin saturation but was not associated with an increase in oxidative stress markers [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/83\">",
"     83",
"    </a>",
"    ]. Studies comparing different iron doses in preterm infants have not been performed and it is unclear whether higher doses of Fe are more beneficial. As a result, there are no data to support this higher Fe supplementation in preterm infants that exceeds the AAP recommended daily Fe intake.",
"   </p>",
"   <p>",
"    Iron supplementation (when full enteral feedings are reached) appears to be beneficial and without adverse effect.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a systematic review of the literature, preterm and low birth weight infants who received iron supplementation had higher hemoglobin levels, improved iron stores, and were less likely to develop iron deficiency compared with infants who did not receive supplementation [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/84\">",
"       84",
"      </a>",
"      ]. Data were insufficient to determine whether iron supplementation had long-term benefits in regards to neurodevelopmental outcome and growth. In addition, the optimum dose of iron supplementation remained unclear as there were no differences in hematologic and neurodevelopmental outcomes between groups of infants who received high and low daily doses of iron (3 versus 2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day).",
"     </li>",
"     <li>",
"      In a subsequently published trial of 285 low birth weight (LBW) infants (birth weights between 2000 and 2500 g), there were no differences in the scores of cognitive testing at 3.5 years of age among patients treated with 0, 1, and 2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day of iron from six weeks to six months of age and 95 normal birth weight controls [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/85\">",
"       85",
"      </a>",
"      ]. However, the risk of behavioral problems detected by the Child Behavior Checklist was greater in the LBW group treated with placebo (ie, no iron supplementation) compared with the other LBW groups who received iron supplementation and the normal birth weight controls. In this cohort of patients, most of the patients were breastfed (91 percent) and half were exclusively breastfed.",
"     </li>",
"     <li>",
"      In a second study that was not included in the systematic review, infants with birth weights below 1800 g fed a premature formula with high Fe (15",
"      <span class=\"nowrap\">",
"       mg/dL)",
"      </span>",
"      content during hospitalization had higher plasma ferritin values and less anemia compared to those fed formula with low Fe content (3",
"      <span class=\"nowrap\">",
"       mg/dL)",
"      </span>",
"      both at discharge and eight weeks later [",
"      <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/86\">",
"       86",
"      </a>",
"      ]. However, as noted above, the benefit of iron intakes &gt;2",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day is not proven. Iron containing formulas contain 1.5",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      of iron.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The timing of supplementation also remains uncertain. In one study that compared timing of iron supplementation defined as early (less than 28 days postnatal age) and late (after 28 days postnatal age), there was no difference in cognitive outcome but there was an increased risk of an abnormal neurologic examination at five years of age in the group assigned to late administration.",
"   </p>",
"   <p>",
"    Based on the above results, we use iron-fortified formula from the onset of feeding in preterm infants not given human milk, because bioavailability is lower (3 to 4 percent) in formula compared to human milk. We provide iron supplementation (minimum of 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day) to infants who are fed human milk after two weeks of age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     ZINC",
"    </span>",
"    &nbsp;&mdash;&nbsp;In premature infants, absorption of zinc is greater in human milk (both unsupplemented and supplemented) compared to either term or premature formula [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/87\">",
"     87",
"    </a>",
"    ]. However, premature infants fed human milk can develop Zn deficiency at several months of age because the Zn concentration in the milk declines as lactation continues [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/88-90\">",
"     88-90",
"    </a>",
"    ]. Human milk fortifiers should contain Zn since the decline in Zn as lactation puts the rapidly growing premature infant at risk for Zn deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/91\">",
"     91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The zinc content in premature formula is approximately 1250",
"    <span class=\"nowrap\">",
"     micrograms/dL,",
"    </span>",
"    which provides enough nutrients for adequate zinc status of premature infants and net retention equal to intrauterine accretion rates [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     COPPER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fortified human milk provides a copper (Cu) intake of 180",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per day and premature formula provides Cu intake of 200 to 300",
"    <span class=\"nowrap\">",
"     mcg/kg",
"    </span>",
"    per day [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/87,92,93\">",
"     87,92,93",
"    </a>",
"    ]. Both surpass the intrauterine accretion rates for premature infants [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     VITAMINS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature infants need higher amounts of some vitamins than do term infants because of increased requirements for growth",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    greater losses. Human milk may not provide sufficient amounts. As an example, plasma concentrations of vitamin C fell rapidly in one study of premature infants fed human milk [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/94\">",
"     94",
"    </a>",
"    ]. Light exposure and passage of milk through feeding tubes reduce concentrations of vitamins such as vitamin A and riboflavin in human milk. A similar study has not been performed on premature formula [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/95\">",
"     95",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Human milk fortifiers and premature formulas provide additional vitamins, although the concentrations may be lower than recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/96\">",
"     96",
"    </a>",
"    ]. If infants receive adequate amounts of fortified human milk or premature formula, additional multivitamin supplements are not needed. A multivitamin supplement should be added when the premature infant begins feeding with unfortified human milk or standard term formula and continued until the infant intake is &gt;300",
"    <span class=\"nowrap\">",
"     kcal/day",
"    </span>",
"    or 450",
"    <span class=\"nowrap\">",
"     mL/day,",
"    </span>",
"    or weighs more than 2.5 kg [",
"    <a class=\"abstract\" href=\"UTD.htm?0/28/458/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following is a summary of the composition of human milk and formula for the premature infant.",
"   </p>",
"   <p>",
"    Nutritional goals in premature infants are to achieve intrauterine rates of growth and nutrient accretion by providing sufficient calories and nutrients. Enteral nutrition can be used to achieve these nutritional goals with either human milk or commercial premature formula. Although human milk is the preferred feeding for all infants, supplementation, utilizing human milk fortifiers, is required to meet the nutritional needs of premature newborns. Premature formula is an appropriate option especially if there is an inadequate supply of mother's milk or if the mother is unable to breastfeed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23655?source=see_link\">",
"     \"Human milk feeding and fortification of human milk for premature infants\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Premature formula replicates many of the components of human milk. Key components include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Protein &ndash; Both human milk and premature formula have a predominance of whey protein. In premature infants, whey protein, when compared to casein protein, promotes more rapid gastric emptying, is more easily digested, and contains proteins that may play a role in host defense. However, neither human milk nor premature formula adequately meet the protein requirements of premature infants and need to be supplemented. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Protein'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lipid &ndash; Lipid comprises nearly 50 percent of the caloric content of milk and is the major energy source. Medium chain fatty acid (MCFA) is increased to 40 percent of lipid content in premature formulas compared with 12 percent in human milk. No proven benefit has been shown with this higher percentage of MCFA in premature formula.",
"      <br/>",
"      <br/>",
"      In contrast, data suggest long-chain polyunsaturated fatty acids are beneficial for premature infants. Premature formula supplementation with arachidonic and docosahexaenoic acids results in concentrations of docosahexaenoic acid in red blood cells, similar to those seen in premature infants fed human milk. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Lipid'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Carbohydrate &ndash; Lactose and oligosaccharides comprise the majority of the carbohydrate content of human milk and contribute approximately 40 percent of the caloric content. In contrast to human milk, current premature formulas usually contain equal proportions of lactose and glucose polymers. This combination results in lower osmolality than does lactose alone. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Carbohydrate'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Electrolytes, minerals, and trace elements &ndash; Human milk does",
"      <strong>",
"       not",
"      </strong>",
"      adequately meet the premature infant's requirements for calcium, phosphorus, iron, and vitamins and, thus, requires supplementation. Zinc and sodium concentrations in human milk decline as lactation continues, and supplementation may be required. There are adequate amounts of magnesium, copper, and potassium in unsupplemented human milk.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Premature formula provides adequate amounts of calcium, phosphorus, vitamins, zinc, magnesium, copper, and potassium. The sodium concentration is low, similar to human milk, and supplementation may be required. In addition, further supplementation of iron may be required beyond the iron intake provided by iron fortified formula.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/1\">",
"      Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 2012; 129:e827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/2\">",
"      Hay WW Jr, Lucas A, Heird WC, et al. Workshop summary: nutrition of the extremely low birth weight infant. Pediatrics 1999; 104:1360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/3\">",
"      Schanler RJ, Garza C, Nichols BL. Fortified mothers' milk for very low birth weight infants: results of growth and nutrient balance studies. J Pediatr 1985; 107:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/4\">",
"      Butte NF, Garza C, Smith EO, Nichols BL. Human milk intake and growth in exclusively breast-fed infants. J Pediatr 1984; 104:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/5\">",
"      Isaacs EB, Morley R, Lucas A. Early diet and general cognitive outcome at adolescence in children born at or below 30 weeks gestation. J Pediatr 2009; 155:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/6\">",
"      Schanler RJ, Garza C. Plasma amino acid differences in very low birth weight infants fed either human milk or whey-dominant cow milk formula. Pediatr Res 1987; 21:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/7\">",
"      Billeaud C, Guillet J, Sandler B. Gastric emptying in infants with or without gastro-oesophageal reflux according to the type of milk. Eur J Clin Nutr 1990; 44:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/8\">",
"      Berger HM, Scott PH, Kenward C, et al. Curd and whey proteins in the nutrition of low birthweight babies. Arch Dis Child 1979; 54:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/9\">",
"      Jakobsson I, Lindberg T, Benediktsson B, Hansson BG. Dietary bovine beta-lactoglobulin is transferred to human milk. Acta Paediatr Scand 1985; 74:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/10\">",
"      Savilahti E, Kuitunen M. Allergenicity of cow milk proteins. J Pediatr 1992; 121:S12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/11\">",
"      Schanler RJ, Goldblum RM, Garza C, Goldman AS. Enhanced fecal excretion of selected immune factors in very low birth weight infants fed fortified human milk. Pediatr Res 1986; 20:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/12\">",
"      Goldblum RM, Schanler RJ, Garza C, Goldman AS. Human milk feeding enhances the urinary excretion of immunologic factors in low birth weight infants. Pediatr Res 1989; 25:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/13\">",
"      R&auml;ih&auml; NC, Heinonen K, Rassin DK, Gaull GE. Milk protein quantity and quality in low-birthweight infants: I. Metabolic responses and effects on growth. Pediatrics 1976; 57:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/14\">",
"      Gaull GE, Rassin DK, R&auml;ih&auml; NC, Heinonen K. Milk protein quantity and quality in low-birth-weight infants. III. Effects on sulfur amino acids in plasma and urine. J Pediatr 1977; 90:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/15\">",
"      Rassin DK, Gaull GE, R&auml;ih&auml; NC, Heinonen K. Milk protein quantity and quality in low-birth-weight infants. IV. Effects on tyrosine and phenylalanine in plasma and urine. J Pediatr 1977; 90:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/16\">",
"      Vi&ntilde;a J, Vento M, Garc&iacute;a-Sala F, et al. L-cysteine and glutathione metabolism are impaired in premature infants due to cystathionase deficiency. Am J Clin Nutr 1995; 61:1067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/17\">",
"      Chesney RW, Helms RA, Christensen M, et al. The role of taurine in infant nutrition. Adv Exp Med Biol 1998; 442:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/18\">",
"      Premji SS, Fenton TR, Sauve RS. Higher versus lower protein intake in formula-fed low birth weight infants. Cochrane Database Syst Rev 2006; :CD003959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/19\">",
"      Cooke R, Embleton N, Rigo J, et al. High protein pre-term infant formula: effect on nutrient balance, metabolic status and growth. Pediatr Res 2006; 59:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/20\">",
"      Brumberg HL, Kowalski L, Troxell-Dorgan A, et al. Randomized trial of enteral protein and energy supplementation in infants less than or equal to 1250 g at birth. J Perinatol 2010; 30:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/21\">",
"      Atkinson SA, Bryan MH, Anderson GH. Human milk: difference in nitrogen concentration in milk from mothers of term and premature infants. J Pediatr 1978; 93:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/22\">",
"      Butte NF, Garza C, Johnson CA, et al. Longitudinal changes in milk composition of mothers delivering preterm and term infants. Early Hum Dev 1984; 9:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/23\">",
"      Gross SJ, David RJ, Bauman L, Tomarelli RM. Nutritional composition of milk produced by mothers delivering preterm. J Pediatr 1980; 96:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/24\">",
"      Schanler RJ, Oh W. Composition of breast milk obtained from mothers of premature infants as compared to breast milk obtained from donors. J Pediatr 1980; 96:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/25\">",
"      Klein CJ. Nutrient requirements for preterm infant formulas. J Nutr 2002; 132:1395S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/26\">",
"      Moro G, Fulconis F, Minoli I, et al. Growth and plasma amino acid concentrations in very low birthweight infants fed either human milk protein fortified human milk or a whey-predominant formula. Acta Paediatr Scand 1989; 78:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/27\">",
"      Kashyap S, Schulze KF, Forsyth M, et al. Growth, nutrient retention, and metabolic response of low-birth-weight infants fed supplemented and unsupplemented preterm human milk. Am J Clin Nutr 1990; 52:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/28\">",
"      R&ouml;nnholm KA, Sipil&auml; I, Siimes MA. Human milk protein supplementation for the prevention of hypoproteinemia without metabolic imbalance in breast milk-fed, very low-birth-weight infants. J Pediatr 1982; 101:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/29\">",
"      Polberger SK, Axelsson IA, R&auml;ih&auml; NC. Growth of very low birth weight infants on varying amounts of human milk protein. Pediatr Res 1989; 25:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/30\">",
"      R&ouml;nnholm KA, Perheentupa J, Siimes MA. Supplementation with human milk protein improves growth of small premature infants fed human milk. Pediatrics 1986; 77:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/31\">",
"      Arslanoglu S, Moro GE, Ziegler EE. Adjustable fortification of human milk fed to preterm infants: does it make a difference? J Perinatol 2006; 26:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/32\">",
"      Moro GE, Minoli I, Fulconis F, et al. Growth and metabolic responses in low-birth-weight infants fed human milk fortified with human milk protein or with a bovine milk protein preparation. J Pediatr Gastroenterol Nutr 1991; 13:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/33\">",
"      Schanler RJ, Abrams SA, Garza C. Bioavailability of calcium and phosphorus in human milk fortifiers and formula for very low birth weight infants. J Pediatr 1988; 113:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/34\">",
"      Hamosh M. Lipid metabolism in premature infants. Biol Neonate 1987; 52 Suppl 1:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/35\">",
"      Jensen RG, Jensen GL. Specialty lipids for infant nutrition. I. Milks and formulas. J Pediatr Gastroenterol Nutr 1992; 15:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/36\">",
"      Innis SM. Human milk and formula fatty acids. J Pediatr 1992; 120:S56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/37\">",
"      Alemi B, Hamosh M, Scanlon JW, et al. Fat digestion in very low-birth-weight infants: effect of addition of human milk to low-birth-weight formula. Pediatrics 1981; 68:484.",
"     </a>",
"    </li>",
"    <li>",
"     Schanler RJ. Special methods in feeding the preterm infant. In: Nutrition During Infancy, Tsang RC, Nichols BL (Eds), Hanley &amp; Belfus, Philadelphia 1988. p.314.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/39\">",
"      Hamosh M, Bitman J, Liao TH, et al. Gastric lipolysis and fat absorption in preterm infants: effect of medium-chain triglyceride or long-chain triglyceride-containing formulas. Pediatrics 1989; 83:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/40\">",
"      Whyte RK, Campbell D, Stanhope R, et al. Energy balance in low birth weight infants fed formula of high or low medium-chain triglyceride content. J Pediatr 1986; 108:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/41\">",
"      Huston RK, Reynolds JW, Jensen C, Buist NR. Nutrient and mineral retention and vitamin D absorption in low-birth-weight infants: effect of medium-chain triglycerides. Pediatrics 1983; 72:44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/42\">",
"      Borum PR. Medium-chain triglycerides in formula for preterm neonates: implications for hepatic and extrahepatic metabolism. J Pediatr 1992; 120:S139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/43\">",
"      Wu PY, Edmond J, Auestad N, et al. Medium-chain triglycerides in infant formulas and their relation to plasma ketone body concentrations. Pediatr Res 1986; 20:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/44\">",
"      Rebouche CJ, Panagides DD, Nelson SE. Role of carnitine in utilization of dietary medium-chain triglycerides by term infants. Am J Clin Nutr 1990; 52:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/45\">",
"      Sulkers EJ, Lafeber HN, van Goudoever JB, et al. Decreased glucose oxidation in preterm infants fed a formula containing medium-chain triglycerides. Pediatr Res 1993; 33:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/46\">",
"      Carlson SE, Rhodes PG, Ferguson MG. Docosahexaenoic acid status of preterm infants at birth and following feeding with human milk or formula. Am J Clin Nutr 1986; 44:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/47\">",
"      Carlson SE, Cooke RJ, Rhodes PG, et al. Long-term feeding of formulas high in linolenic acid and marine oil to very low birth weight infants: phospholipid fatty acids. Pediatr Res 1991; 30:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/48\">",
"      Clandinin MT, Parrott A, Van Aerde JE, et al. Feeding preterm infants a formula containing C20 and C22 fatty acids simulates plasma phospholipid fatty acid composition of infants fed human milk. Early Hum Dev 1992; 31:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/49\">",
"      Innis SM, Foote KD, MacKinnon MJ, King DJ. Plasma and red blood cell fatty acids of low-birth-weight infants fed their mother's expressed breast milk or preterm-infant formula. Am J Clin Nutr 1990; 51:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/50\">",
"      Uauy R, Hoffman DR. Essential fatty acid requirements for normal eye and brain development. Semin Perinatol 1991; 15:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/51\">",
"      O'Connor DL, Hall R, Adamkin D, et al. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics 2001; 108:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/52\">",
"      Simmer K, Schulzke SM, Patole S. Long-chain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 2008; :CD000375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/53\">",
"      Clandinin MT, Van Aerde JE, Merkel KL, et al. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J Pediatr 2005; 146:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/54\">",
"      Simmer K, Patole SK, Rao SC. Long-chain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev 2011; :CD000376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/55\">",
"      Makrides M, Gibson RA, McPhee AJ, et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA 2009; 301:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/56\">",
"      Smithers LG, Collins CT, Simmonds LA, et al. Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial. Am J Clin Nutr 2010; 91:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/57\">",
"      Beyerlein A, Hadders-Algra M, Kennedy K, et al. Infant formula supplementation with long-chain polyunsaturated fatty acids has no effect on Bayley developmental scores at 18 months of age--IPD meta-analysis of 4 large clinical trials. J Pediatr Gastroenterol Nutr 2010; 50:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/58\">",
"      de Jong C, Boehm G, Kikkert HK, Hadders-Algra M. The Groningen LCPUFA study: No effect of short-term postnatal long-chain polyunsaturated fatty acids in healthy term infants on cardiovascular and anthropometric development at 9 years. Pediatr Res 2011; 70:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/59\">",
"      Isaacs EB, Ross S, Kennedy K, et al. 10-year cognition in preterms after random assignment to fatty acid supplementation in infancy. Pediatrics 2011; 128:e890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/60\">",
"      Butte NF, Garza C, Smith EO. Variability of macronutrient concentrations in human milk. Eur J Clin Nutr 1988; 42:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/61\">",
"      Hall B. Uniformity of human milk. Am J Clin Nutr 1979; 32:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/62\">",
"      Neville MC, Keller RP, Seacat J, et al. Studies on human lactation. I. Within-feed and between-breast variation in selected components of human milk. Am J Clin Nutr 1984; 40:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/63\">",
"      Valentine CJ, Hurst NM, Schanler RJ. Hindmilk improves weight gain in low-birth-weight infants fed human milk. J Pediatr Gastroenterol Nutr 1994; 18:474.",
"     </a>",
"    </li>",
"    <li>",
"     Polberger S. Quality of growth in preterm neonates fed individually fortified human milk. In: Maternal and Extrauterine Nutritional Factors: Their Influence on Fetal and Infant Growth, Battaglia FC, Pedraz C, Sawatzki G, et al (Eds), Ediciones Ergon, SA, Madrid 1996. p.395.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/65\">",
"      Greer FR, McCormick A, Loker J. Changes in fat concentration of human milk during delivery by intermittent bolus and continuous mechanical pump infusion. J Pediatr 1984; 105:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/66\">",
"      Mehta NR, Hamosh M, Bitman J, Wood DL. Adherence of medium-chain fatty acids to feeding tubes during gavage feeding of human milk fortified with medium-chain triglycerides. J Pediatr 1988; 112:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/67\">",
"      Atkinson SA, Bryan MH, Anderson GH. Human milk feeding in premature infants: protein, fat, and carbohydrate balances in the first two weeks of life. J Pediatr 1981; 99:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/68\">",
"      De Curtis M, Senterre J, Rigo J. Estimated and measured energy content of infant formulas. J Pediatr Gastroenterol Nutr 1986; 5:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/69\">",
"      Whyte RK, Homer R, Pennock CA. Faecal excretion of oligosaccharides and other carbohydrates in normal neonates. Arch Dis Child 1978; 53:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/70\">",
"      MacLean WC Jr, Fink BB. Lactose malabsorption by premature infants: magnitude and clinical significance. J Pediatr 1980; 97:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/71\">",
"      Ziegler EE, Fomon SJ. Lactose enhances mineral absorption in infancy. J Pediatr Gastroenterol Nutr 1983; 2:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/72\">",
"      Shulman RJ, Schanler RJ, Lau C, et al. Early feeding, feeding tolerance, and lactase activity in preterm infants. J Pediatr 1998; 133:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/73\">",
"      Wirth FH Jr, Numerof B, Pleban P, Neylan MJ. Effect of lactose on mineral absorption in preterm infants. J Pediatr 1990; 117:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/74\">",
"      Schanler RJ, Rifka M. Calcium, phosphorus and magnesium needs for the low-birth-weight infant. Acta Paediatr Suppl 1994; 405:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/75\">",
"      Schanler RJ, Abrams SA. Postnatal attainment of intrauterine macromineral accretion rates in low birth weight infants fed fortified human milk. J Pediatr 1995; 126:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/76\">",
"      Roy RN, Chance GW, Radde IC, et al. Late hyponatremia in very low birthweight infants. (less than 1.3 kilograms). Pediatr Res 1976; 10:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/77\">",
"      Kumar SP, Sacks LM. Hyponatremia in very low-birth-weight infants and human milk feedings. J Pediatr 1978; 93:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/78\">",
"      Siimes MA, Vuori E, Kuitunen P. Breast milk iron--a declining concentration during the course of lactation. Acta Paediatr Scand 1979; 68:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/79\">",
"      Dauncey MJ, Davies CG, Shaw JC, Urman J. The effect of iron supplements and blood transfusion on iron absorption by low birthweight infants fed pasteurized human breast milk. Pediatr Res 1978; 12:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/80\">",
"      Moody GJ, Schanler RJ, Abrams SA. Utilization of supplemental iron by premature infants fed fortified human milk. Acta Paediatr 1999; 88:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/81\">",
"      Lundstr&ouml;m U, Siimes MA, Dallman PR. At what age does iron supplementation become necessary in low-birth-weight infants? J Pediatr 1977; 91:878.",
"     </a>",
"    </li>",
"    <li>",
"     Committee on Nutrition, American Academy of Pediatrics. Nutritional needs of the preterm infant. In: Pediatric Nutrition Handbook, 6th ed, Kleinman RE (Ed), American Academy of Pediatrics, Elk Grove Village 2009. p.79.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/83\">",
"      Braekke K, Bechensteen AG, Halvorsen BL, et al. Oxidative stress markers and antioxidant status after oral iron supplementation to very low birth weight infants. J Pediatr 2007; 151:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/84\">",
"      Mills RJ, Davies MW. Enteral iron supplementation in preterm and low birth weight infants. Cochrane Database Syst Rev 2012; 3:CD005095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/85\">",
"      Berglund SK, Westrup B, H&auml;ggl&ouml;f B, et al. Effects of iron supplementation of LBW infants on cognition and behavior at 3 years. Pediatrics 2013; 131:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/86\">",
"      Hall RT, Wheeler RE, Benson J, et al. Feeding iron-fortified premature formula during initial hospitalization to infants less than 1800 grams birth weight. Pediatrics 1993; 92:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/87\">",
"      Ehrenkranz RA, Gettner PA, Nelli CM, et al. Zinc and copper nutritional studies in very low birth weight infants: comparison of stable isotopic extrinsic tag and chemical balance methods. Pediatr Res 1989; 26:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/88\">",
"      Sievers E, Oldigs HD, D&ouml;rner K, Schaub J. Longitudinal zinc balances in breast-fed and formula-fed infants. Acta Paediatr 1992; 81:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/89\">",
"      Bilinski DL, Ehrenkranz RA, Cooley-Jacobs J, McGuire J. Symptomatic zinc deficiency in a breast-fed, premature infant. Arch Dermatol 1987; 123:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/90\">",
"      Kienast A, Roth B, Bossier C, et al. Zinc-deficiency dermatitis in breast-fed infants. Eur J Pediatr 2007; 166:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/91\">",
"      Obladen M, Loui A, Kampmann W, Renz H. Zinc deficiency in rapidly growing preterm infants. Acta Paediatr 1998; 87:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/92\">",
"      Tyrala EE. Zinc and copper balances in preterm infants. Pediatrics 1986; 77:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/93\">",
"      Schanler RJ, Shulman RJ, Lau C. Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. Pediatrics 1999; 103:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/94\">",
"      Heinonen K, Mononen I, Mononen T, et al. Plasma vitamin C levels are low in premature infants fed human milk. Am J Clin Nutr 1986; 43:923.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/95\">",
"      Bates CJ, Liu DS, Fuller NJ, Lucas A. Susceptibility of riboflavin and vitamin A in breast milk to photodegradation and its implications for the use of banked breast milk in infant feeding. Acta Paediatr Scand 1985; 74:40.",
"     </a>",
"    </li>",
"    <li>",
"     Schanler RJ. Water soluble vitamins: C, B1,B2, B6, niacin, biotin, and pantothenic acid. In: Nutrition During Infancy, Tsang RC, Nichols BL (Eds), Hanley &amp; Belfus, Philadelphia 1988. p.236.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?0/28/458/abstract/97\">",
"      Vitamin and mineral supplement needs in normal children in the United States. Pediatrics 1980; 66:101.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5047 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-F1B7A60FFB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_28_458=[""].join("\n");
var outline_f0_28_458=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PROTEIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Whey predominance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Amino acid content",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Requirements",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Supplementation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      LIPID",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Medium chain fatty acids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Long-chain polyunsaturated fatty acids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Lipid in human milk",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Delivery of lipid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      CARBOHYDRATE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      CALCIUM AND PHOSPHORUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      MAGNESIUM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SODIUM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      POTASSIUM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      IRON",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      ZINC",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      COPPER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      VITAMINS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5047\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5047|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/11/38077\" title=\"table 1\">",
"      Nutrient requirements premature",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/32/27147\" title=\"table 2\">",
"      Energy requirements premature",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/24/23947\" title=\"table 3\">",
"      Intrauterine nutrient accretion",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/8/19593?source=related_link\">",
"      Approach to enteral nutrition in the premature infant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40567?source=related_link\">",
"      Calcium and phosphorus requirements of newborn infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/27/10680?source=related_link\">",
"      Clinical features and etiology of colic",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/29/14808?source=related_link\">",
"      Clinical manifestations of food allergy: An overview",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/6/23655?source=related_link\">",
"      Human milk feeding and fortification of human milk for premature infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22826?source=related_link\">",
"      Iron deficiency in infants and young children: Screening, prevention, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/36/6727?source=related_link\">",
"      Nutritional composition of human milk for full-term infants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/50/27434?source=related_link\">",
"      Parenteral nutrition in premature infants",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f0_28_459="Calculation of BMI";
var content_f0_28_459=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71431&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71431&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Calculation of body mass index (BMI)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        English formula for BMI:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        703 x Weight in pounds &divide; (Height in inches)",
"        <sup>",
"         2",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Metric formula for BMI:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Weight in Kilograms &divide; (Height in meters)",
"        <sup>",
"         2",
"        </sup>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_28_459=[""].join("\n");
var outline_f0_28_459=null;
var title_f0_28_460="Hereditary RCC syndromes";
var content_f0_28_460=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F53600&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F53600&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical and molecular characteristics of hereditary kidney cancer syndromes",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Syndrome",
"       </td>",
"       <td class=\"subtitle1\">",
"        Gene/protein",
"       </td>",
"       <td class=\"subtitle1\">",
"        Potential pathway",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HPRC",
"       </td>",
"       <td>",
"        c-MET",
"       </td>",
"       <td>",
"        HGF/MET",
"       </td>",
"       <td>",
"        Papillary type I RCC",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HLRCC",
"       </td>",
"       <td>",
"        FH",
"       </td>",
"       <td>",
"        Krebs cycle/HIF1",
"       </td>",
"       <td>",
"        Papillary type II RCC/skin and uterine leimyoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        BHD",
"       </td>",
"       <td>",
"        Folliculin",
"       </td>",
"       <td>",
"        mTOR",
"       </td>",
"       <td>",
"        Chromophobe/oncocytic/hybrid/clear cell RCC/fibrofolliculoma, pulmonary cysts/pneumothorax",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HPP",
"       </td>",
"       <td>",
"        SDH",
"       </td>",
"       <td>",
"        Krebs cycle/hypoxia",
"       </td>",
"       <td>",
"        Clear cell/chromophobe RCC, pheochromocytom/paragangliomas",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        TSC",
"       </td>",
"       <td>",
"        TSC1/TSC2",
"       </td>",
"       <td>",
"        mTOR",
"       </td>",
"       <td>",
"        Clear cell RCC, angiomyolipoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VHL",
"       </td>",
"       <td>",
"        VHL gene",
"       </td>",
"       <td>",
"        HIF-1",
"       </td>",
"       <td>",
"        Clear cell RCC, hemangioblastomas, retinal angiomas, pheochromocytomas, endolymphatic sac tumors of the middle ear",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     BHD: Birt-Hogg-Dube; HGF: hepatocyte growth factor; HLRCC: hereditary leiomyomatosis renal cell carcinoma; HPP: hereditary paraganglioma/pheochromocytoma; HPRC: hereditary papillary renal cancer; mTOR: mammalian target of rapamycin; RCC: renal cell carcinoma; TSC: tuberous sclerosis complex; VHL: von Hippel-Lindau; HIF-1: hypoxia-inducible factor 1.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_28_460=[""].join("\n");
var outline_f0_28_460=null;
var title_f0_28_461="DDx HCL path";
var content_f0_28_461=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F88275&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F88275&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of hairy cell leukemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Entity",
"       </td>",
"       <td class=\"subtitle1\">",
"        Histology",
"       </td>",
"       <td class=\"subtitle1\">",
"        Immunophenotype",
"       </td>",
"       <td class=\"subtitle1\">",
"        Genetic features/other",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Hairy cell leukemia",
"       </td>",
"       <td>",
"        The HCL cell is mononuclear and one to two times the size of a mature lymphocyte. The nuclei are often eccentric, lack prominent nucleoli, and have a reticular chromatin pattern. The cytoplasm is often abundant and pale blue to blue-gray in color. The cytoplasmic outline is indistinct with varying numbers of projections. Characteristically infiltrates the marrow in an interstitial or diffuse pattern; nodular aggregates are absent.",
"       </td>",
"       <td>",
"        Most cases of HCL express CD20, CD22, CD11c, CD103, CD123, and CD25. Expression of cyclin D1 and annexin A1 is variable. Expression of CD20 and surface immunoglobulin is bright. Rare cases express CD5 or CD10.",
"       </td>",
"       <td>",
"        Approximately 75 percent have BRAF V600E mutation.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Hairy cell leukemia variant",
"       </td>",
"       <td>",
"        Variant has circulating tumor cells with morphology intermediate between hairy cells and prolymphocytes. Nucleoli are prominent.",
"       </td>",
"       <td>",
"        Express CD20, CD22, CD11c, and CD103. Expression of CD123 is dim or negative. Do not express annexin A1 or CD25. Expression of CD20 and surface immunoglobulin is bright.",
"       </td>",
"       <td>",
"        Initial reports suggest that HCL variants usually lack the BRAF V600E mutation.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Chronic lymphocytic leukemia/small lymphocytic lymphoma",
"       </td>",
"       <td>",
"        \"Typical\" CLL cells are small, mature appearing lymphocytes with a dense nucleus, partially aggregated chromatin; no discernible nucleoli; and a narrow border of clear to slightly basophilic cytoplasm. Often involves the marrow as nodular aggregates, sometimes with proliferation centers.",
"       </td>",
"       <td>",
"        Typically express CD5 and CD23. Expression of CD20 and surface immunoglobulin is dim. Do not express annexin A1.",
"       </td>",
"       <td>",
"        Trisomy 12, deletions of 6q, 11q, 13q, and 17p.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        B cell prolymphocytic leukemia",
"       </td>",
"       <td>",
"        <p>",
"         &gt;55 percent (and usually &gt;90 percent) of circulating white cells are \"prolymphocytes\": medium-sized cells with moderately abundant, slightly basophilic cytoplasm; a round or oval nucleus with moderately condensed chromatin; and a single, prominent nucleolus.",
"        </p>",
"        The bone marrow is infiltrated in an interstitial or nodular pattern by similar cells.",
"       </td>",
"       <td>",
"        <p>",
"         Express bright surface IgM +/&ndash; IgD and bright CD20 as well as other B cell antigens (CD19, CD22, CD79a, FMC7).",
"        </p>",
"        CD5 and CD23 expression is usually weak or absent. CD11c, CD103, CD10, CD25, and cyclin D1 are not expressed. Do not express annexin A1.",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Splenic marginal zone lymphoma",
"       </td>",
"       <td>",
"        Splenic MZL cells usually have short polar villi. Both white and red pulp of the spleen are involved. Nodular pattern of marrow involvement.",
"       </td>",
"       <td>",
"        Do not express CD103 or annexin A1. Expression of CD20 and surface immunoglobulin is bright.",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mantle cell lymphoma",
"       </td>",
"       <td>",
"        Can have a leukemic phase.",
"       </td>",
"       <td>",
"        Typically positive for IgM, IgD, CD20 and CD5 and negative for CD23 negative. Express cyclin D1.",
"       </td>",
"       <td>",
"        t(11;14)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     HCL: hairy cell leukemia; CLL: chronic lymphocytic leukemia; MZL: marginal zone lymphoma.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_28_461=[""].join("\n");
var outline_f0_28_461=null;
var title_f0_28_462="Contents: Child and adolescent mental disorders";
var content_f0_28_462=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?1/34/1568\">",
"       Family Medicine and General Practice",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Child and adolescent mental disorders",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Child and adolescent mental disorders",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Attention deficit hyperactivity disorder",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/63/32761\">",
"           Adult attention deficit hyperactivity disorder",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/7/20599\">",
"           Pharmacotherapy for adult ADHD",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pediatric anxiety",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/5/30808\">",
"           Overview of fears and specific phobias in children",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pediatric bipolar disorder",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/33/32279\">",
"           Bipolar disorder in children and adolescents: Assessment and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/56/38791\">",
"           Bipolar disorder in children and adolescents: Epidemiology, pathogenesis, clinical manifestations, and course",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pediatric depression",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/10/5289\">",
"           Depression in adolescents: Epidemiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/23/15736\">",
"           Effect of antidepressants on suicide risk in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/11/38071\">",
"           Evaluation and management of suicidal behavior in children and adolescents",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/26/13738\">",
"           Overview of treatment for adolescent depression",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?29/52/30538\">",
"           Psychopharmacological treatment for adolescent depression",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/14/4328\">",
"           Psychosocial treatment for adolescent depression",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/17/23834\">",
"           Suicidal behavior in children and adolescents: Epidemiology and risk factors",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-9D689C6A50-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f0_28_462=[""].join("\n");
var outline_f0_28_462=null;
var title_f0_28_463="Erythema nodosum IBD";
var content_f0_28_463=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F71344&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F71344&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema nodosum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 259px; height: 262px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patient with inflammatory bowel disease with red nodular areas on the shins which are characteristic of erythema nodosum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of the American Gastroenterological Association&copy;. This slide cannot be downloaded but may be purchased as part of a set from the AGA through Milner-Fenwick, Inc at 1-800-432-8433.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f0_28_463=[""].join("\n");
var outline_f0_28_463=null;
              